| Ajugol, Alternative-names: , CAS# 52949-83-4, Formula: C15H24O9, MWT: 348.3457, Solubility: DMSO: ≥ 3.7 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Melittoside, Alternative-names: , CAS# 19467-03-9, Formula: C21H32O15, MWT: 524.4698, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SAG, Alternative-names: , CAS# 912545-86-9, Formula: C28H28ClN3OS, MWT: 490.0594, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt, Target: Smo, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| PFI-2, Alternative-names: (R)-PFI-2, CAS# 1627676-59-8, Formula: C23H25F4N3O3S, MWT: 499.5215, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| PFI-2 (hydrochloride), Alternative-names: (R)-PFI-2 hydrochloride, CAS# 1627607-87-7, Formula: C23H26ClF4N3O3S, MWT: 535.9825, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| GSK503, Alternative-names: , CAS# 1346572-63-1, Formula: C31H38N6O2, MWT: 526.6724, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Epigenetics, Target: Histone Methyltransferase;Epigenetic Reader Domain, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Pivmecillinam, Alternative-names: Amdinocillin pivoxil, CAS# 32886-97-8, Formula: C21H33N3O5S, MWT: 439.5688, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| OAC1, Alternative-names: , CAS# 300586-90-7, Formula: C14H11N3O, MWT: 237.2566, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt, Target: Oct3/4, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| URMC-099, Alternative-names: , CAS# 1229582-33-5, Formula: C27H27N5, MWT: 421.5368, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway;Autophagy, Target: Mixed Lineage Kinase;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| FIPI, Alternative-names: 5-Fluoro-2-indolyl deschlorohalopemide, CAS# 939055-18-2, Formula: C23H24FN5O2, MWT: 421.4674, Solubility: DMSO: 14.67 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy;Metabolic Enzyme/Protease, Target: Autophagy;Phospholipase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| STF-118804, Alternative-names: , CAS# 894187-61-2, Formula: C25H23N3O4S, MWT: 461.5328, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Nampt, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Optovin, Alternative-names: , CAS# 348575-88-2, Formula: C15H13N3OS2, MWT: 315.4132, Solubility: DMSO: ≥ 37 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: TRP Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| EHop-016, Alternative-names: , CAS# 1380432-32-5, Formula: C25H30N6O, MWT: 430.5453, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Ras, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| OAC2, Alternative-names: , CAS# 6019-39-2, Formula: C15H12N2O, MWT: 236.2686, Solubility: DMSO: ≥ 2.4 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt, Target: Oct3/4, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| GSK2801, Alternative-names: , CAS# 1619994-68-1, Formula: C20H21NO4S, MWT: 371.45, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Epigenetic Reader Domain, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| AZD1981, Alternative-names: , CAS# 802904-66-1, Formula: C19H17ClN2O3S, MWT: 388.8679, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Phase 2, Pathway: GPCR/G Protein;Immunology/Inflammation, Target: CRTH2 (GPR44);CRTH2 (GPR44), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Sal003, Alternative-names: , CAS# 1164470-53-4, Formula: C18H15Cl4N3OS, MWT: 463.2082, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Phosphatase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| BNC105, Alternative-names: , CAS# 945771-74-4, Formula: C20H20O7, MWT: 372.3686, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Cell Cycle/DNA Damage;Cytoskeleton, Target: Microtubule/Tubulin;Microtubule/Tubulin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Scopine (hydrochloride), Alternative-names: 6,7-Epoxytropine hydrochloride, CAS# 85700-55-6, Formula: C8H14ClNO2, MWT: 191.6553, Solubility: DMSO: 15 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Terbutaline (sulfate), Alternative-names: Terbutaline hemisulfate, CAS# 23031-32-5, Formula: C12H19NO3 . 1/2H2O4S, MWT: 274.32, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| PF 05089771, Alternative-names: , CAS# 1235403-62-9, Formula: C18H12Cl2FN5O3S2, MWT: 500.354, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: Phase 2, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ifenprodil (tartrate), Alternative-names: , CAS# 23210-58-4, Formula: C21H27NO2 . 1/2C4H6O6, MWT: 400.49, Solubility: DMSO: ≥ 500 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Cevipabulin, Alternative-names: TTI-237, CAS# 849550-05-6, Formula: C18H18ClF5N6O, MWT: 464.820136, Solubility: DMSO: 10 mg/mL, Clinical_Information: Phase 1, Pathway: Cell Cycle/DNA Damage;Cytoskeleton, Target: Microtubule/Tubulin;Microtubule/Tubulin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| ML RR-S2 CDA, Alternative-names: STING-Inducer-1, CAS# 1638241-89-0, Formula: C20H24N10O10P2S2, MWT: 690.5431, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: STING, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| AZD5582, Alternative-names: , CAS# 1258392-53-8, Formula: C58H78N8O8, MWT: 1015.289, Solubility: DMSO: ≥ 66.25 mg/mL, Clinical_Information: No Development Reported, Pathway: Apoptosis, Target: IAP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| RBC8, Alternative-names: , CAS# 361185-42-4, Formula: C25H20N4O3, MWT: 424.4513, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Ras, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Autotaxin modulator 1, Alternative-names: , CAS# 1548743-69-6, Formula: C28H31F6NO3, MWT: 543.5411, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PDE10-IN-1, Alternative-names: , CAS# 1516896-09-5, Formula: C21H19N7, MWT: 369.4225, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Pepstatin, Alternative-names: Pepstatin A;Isovaleryl-Val-Val-Sta-Ala-Sta-OH, CAS# 26305-03-3, Formula: C34H63N5O9, MWT: 685.8921, Solubility: DMSO: ≥ 25 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Cathepsin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Cyclo(-RGDfK), Alternative-names: Cyclo(RGDfK) peptide;Cyclic RGDfK peptide, CAS# 161552-03-0, Formula: C27H41N9O7, MWT: 603.6705, Solubility: DMSO: ≥ 150 mg/mL, Clinical_Information: No Development Reported, Pathway: Cytoskeleton, Target: Integrin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| RNPA1000, Alternative-names: , CAS# 359600-10-5, Formula: C23H18BrN3O3, MWT: 464.3113, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| BHPI, Alternative-names: , CAS# 56632-39-4, Formula: C21H17NO3, MWT: 331.3646, Solubility: DMSO: ≥150 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Mcl1-IN-2, Alternative-names: , CAS# 292057-76-2, Formula: C19H15N3OS, MWT: 333.4069, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Apoptosis, Target: Bcl-2 Family, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Sortin1, Alternative-names: , CAS# 503837-98-7, Formula: C26H19NO6, MWT: 441.4322, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| KH-CB19, Alternative-names: , CAS# 1354037-26-5, Formula: C15H13Cl2N3O2, MWT: 338.1886, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: CDK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| ML204, Alternative-names: , CAS# 5465-86-1, Formula: C15H18N2, MWT: 226.3168, Solubility: DMSO: ≥ 37 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: TRP Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| FG-2216, Alternative-names: YM-311, CAS# 223387-75-5, Formula: C12H9ClN2O4, MWT: 280.6638, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: HIF/HIF Prolyl-Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Enoxacin (hydrate), Alternative-names: Enoxacin sesquihydrate;AT-2266 hydrate;CI-919 hydrate, CAS# 84294-96-2, Formula: C15H17FN4O3 . 3/2 H2O, MWT: 347.34, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fenoldopam (mesylate), Alternative-names: Fenoldopam methanesulfonate;SKF-82526 mesylate, CAS# 67227-57-0, Formula: C17H20ClNO6S, MWT: 401.8618, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| SR-3306, Alternative-names: , CAS# 1128096-91-2, Formula: C28H26N8O, MWT: 490.5591, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway, Target: JNK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| M-110, Alternative-names: , CAS# 1395048-49-3, Formula: C22H28ClN5O3, MWT: 445.9424, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: JAK/STAT Signaling, Target: Pim, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Ampkinone, Alternative-names: , CAS# 1233082-79-5, Formula: C31H23NO6, MWT: 505.5174, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics;PI3K/Akt/mTOR, Target: AMPK;AMPK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| JNJ-42041935, Alternative-names: , CAS# 1193383-09-3, Formula: C12H6ClF3N4O3, MWT: 346.6493, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: HIF/HIF Prolyl-Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| AMZ30, Alternative-names: , CAS# 1313613-09-0, Formula: C19H12FN3O6S2, MWT: 461.4435, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| MK2-IN-1, Alternative-names: MK2 Inhibitor, CAS# 1314118-92-7, Formula: C27H25ClN4O2, MWT: 472.966, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway, Target: MAPKAPK2 (MK2), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| S1P1 Agonist III, Alternative-names: , CAS# 1324003-64-6, Formula: C21H16F3N3O3, MWT: 415.3652, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: LPL Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| IFN alpha-IFNAR-IN-1, Alternative-names: IFN-alpha and IFNAR interaction inhibitor, CAS# 844882-93-5, Formula: C18H17NS, MWT: 279.3993, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: IFNAR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Fenoprofen (Calcium hydrate), Alternative-names: Fenoprofen calcium salt dihydrate, CAS# 71720-56-4, Formula: C15H16Ca0.5O4+, MWT: 280.32359142, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Pivmecillinam (hydrochloride), Alternative-names: Amdinocillin pivoxil hydrochloride, CAS# 32887-03-9, Formula: C21H34ClN3O5S, MWT: 476.0298, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| EN460, Alternative-names: , CAS# 496807-64-8, Formula: C22H12ClF3N2O4, MWT: 460.7899, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Mirk-IN-1, Alternative-names: Dyrk1B/A-IN-1, CAS# 1386979-55-0, Formula: C23H17Cl2N5O4, MWT: 498.3182, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: DYRK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| p38 MAPK-IN-1, Alternative-names: , CAS# 1006378-90-0, Formula: C21H15F2N2O, MWT: 349.3534, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway, Target: p38 MAPK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| OBA-09, Alternative-names: , CAS# 856095-68-6, Formula: C10H8O5, MWT: 208.1675, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| UC-112, Alternative-names: , CAS# 383392-66-3, Formula: C22H24N2O2, MWT: 348.4382, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Apoptosis, Target: IAP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Z-Gly-Gly-Arg-AMC, Alternative-names: Z-GGRAMC, CAS# 66216-78-2, Formula: C28H33N7O7, MWT: 579.6043, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Tos-Gly-Pro-Arg-ANBA-IPA, Alternative-names: tos-GPR-ANBA-IPA, CAS# 99700-50-2, Formula: C30H41N9O8S, MWT: 687.767, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| D-Lys(Z)-Pro-Arg-pNA, Alternative-names: H-DLys (Cbo)-Pro-Arg-pNA;Chromozym Pca, CAS# 108963-69-5, Formula: C31H43N9O7, MWT: 653.7292, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| pGlu-Pro-Arg-MNA, Alternative-names: , CAS# 130835-45-9, Formula: C23H32N8O7, MWT: 532.5496, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Dinoprost, Alternative-names: Prostaglandin F2a;PGF2α, CAS# 551-11-1, Formula: C20H34O5, MWT: 354.481, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Dinoprost (tromethamine salt), Alternative-names: Prostaglandin F2a tromethamine salt;PGF2α THAM;Prostaglandin F2α THAM, CAS# 38562-01-5, Formula: C24H45NO8, MWT: 475.616, Solubility: H<sub>2</sub>O: ≥ 4.8 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Tegaserod (maleate), Alternative-names: SDZ-HTF-919;HTF-919, CAS# 189188-57-6, Formula: C20H27N5O5, MWT: 417.4589, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Trimebutine (maleate), Alternative-names: , CAS# 34140-59-5, Formula: C26H33NO9, MWT: 503.5415, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Opioid Receptor;Opioid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Monomelittoside, Alternative-names: Danmelittoside, CAS# 20633-72-1, Formula: C15H22O10, MWT: 362.3292, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Daidzin, Alternative-names: Daidzoside;NPI-031D;Daidzein 7-O-glucoside, CAS# 552-66-9, Formula: C21H20O9, MWT: 416.3781, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: Phase 1, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Glycitein, Alternative-names: Glycetein, CAS# 40957-83-3, Formula: C16H12O5, MWT: 284.2635, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Glycitin, Alternative-names: Glycitein 7-O-β-glucoside, CAS# 40246-10-4, Formula: C22H22O10, MWT: 446.4041, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Genistin, Alternative-names: Genistine;Genistoside;Genistein 7-O-β-D-glucopyranoside, CAS# 529-59-9, Formula: C21H20O10, MWT: 432.3775, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy;NF-κB, Target: Autophagy;NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| 6''-O-Malonylgenistin, Alternative-names: Malonylgenistin;Genistin malonate, CAS# 51011-05-3, Formula: C24H22O13, MWT: 518.4237, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Desmethoxyyangonin, Alternative-names: Demethoxyyangonin;5,6-Dehydrokavain, CAS# 15345-89-8, Formula: C14H12O3, MWT: 228.2433, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Yangonin, Alternative-names: , CAS# 500-62-9, Formula: C15H14O4, MWT: 258.2693, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Dihydrokavain, Alternative-names: 7,8-Dihydrokawain;7,8-Dihydrokavain;Marindinin, CAS# 587-63-3, Formula: C14H16O3, MWT: 232.275, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Dihydromethysticin, Alternative-names: (+)-Dihydromethysticin, CAS# 19902-91-1, Formula: C15H16O5, MWT: 276.2845, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Cytochrome P450, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Methysticin, Alternative-names: DL-Methysticin;(±)-Methystici, CAS# 20697-20-5, Formula: C15H14O5, MWT: 274.2686, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: NF-κB, Target: NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Corydaline, Alternative-names: (+)-Corydaline;Corydalin, CAS# 518-69-4, Formula: C22H27NO4, MWT: 369.4541, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Protopine, Alternative-names: Corydinine, CAS# 130-86-9, Formula: C20H19NO5, MWT: 353.3686, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Tetrahydrocoptisine, Alternative-names: (RS)-Stylopine;(±)-Stylopin, CAS# 4312-32-7, Formula: C19H17NO4, MWT: 323.3426, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Coptisine, Alternative-names: Coptisin, CAS# 3486-66-6, Formula: C19H14NO4+, MWT: 320.3182, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Tetrahydroberberine, Alternative-names: Canadine, CAS# 522-97-4, Formula: C20H21NO4, MWT: 339.385, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Columbamine, Alternative-names: Columbamin;Dehydroisocorypalmine, CAS# 3621-36-1, Formula: C20H20NO4+, MWT: 338.3766, Solubility: DMSO: ≥ 23 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| (-)-Isocorypalmine, Alternative-names: Tetrahydrocolumbamine;(S)-Tetrahydrocolumbamine, CAS# 483-34-1, Formula: C20H23NO4, MWT: 341.4009, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pexidartinib, Alternative-names: PLX-3397, CAS# 1029044-16-3, Formula: C20H15ClF3N5, MWT: 417.8148, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Phase 1, Pathway: Protein Tyrosine Kinase/RTK;Protein Tyrosine Kinase/RTK, Target: c-Fms;c-Kit, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Argatroban (monohydrate), Alternative-names: Argipidine monohydrate, CAS# 141396-28-3, Formula: C23H38N6O6S, MWT: 526.6494, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Thrombin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| BS-181 (hydrochloride), Alternative-names: , CAS# 1397219-81-6, Formula: C22H33ClN6, MWT: 416.9906, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: CDK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| NMDA-IN-1, Alternative-names: , CAS# 700878-19-9, Formula: C20H23ClFN3O, MWT: 375.8675, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Caftaric acid, Alternative-names: trans-Caftaric acid, CAS# 67879-58-7, Formula: C13H12O9, MWT: 312.229, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Rosmarinic acid, Alternative-names: Labiatenic acid, CAS# 20283-92-5, Formula: C18H16O8, MWT: 360.3148, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Phase 4, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Cichoric Acid, Alternative-names: Cichoric acid;Dicaffeoyltartaric acid, CAS# 6537-80-0, Formula: C22H18O12, MWT: 474.3711, Solubility: DMSO: ≥ 347 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| L-Chicoric Acid, Alternative-names: (-)-Chicoric acid;trans-Caffeoyltartaric acid, CAS# 70831-56-0, Formula: C22H18O12, MWT: 474.37112, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Mupirocin, Alternative-names: BRL-4910A;Pseudomonic acid, CAS# 12650-69-0, Formula: C26H44O9, MWT: 500.6222, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Tetrahydropalmatine, Alternative-names: DL-Tetrahydropalmatine, CAS# 2934-97-6, Formula: C21H25NO4, MWT: 355.4275, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Stem Cell/Wnt;MAPK/ERK Pathway, Target: ERK;ERK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Tanshinone IIA, Alternative-names: Dan Shen ketone, CAS# 568-72-9, Formula: C19H18O3, MWT: 294.3444, Solubility: DMSO, Clinical_Information: Phase 4, Pathway: Protein Tyrosine Kinase/RTK, Target: VEGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Tanshinone IIA sulfonate (sodium), Alternative-names: Sodium Tanshinone IIA sulfonate;Tanshinone IIA sodium sulfonate, CAS# 69659-80-9, Formula: C19H17NaO6S, MWT: 396.39, Solubility: DMSO: ≥ 106.66 mg/mL, Clinical_Information: Phase 4, Pathway: Protein Tyrosine Kinase/RTK, Target: VEGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Dihydrotanshinone I, Alternative-names: , CAS# 87205-99-0, Formula: C18H14O3, MWT: 278.302, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Paeonol, Alternative-names: , CAS# 552-41-0, Formula: C9H10O3, MWT: 166.1739, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Nuciferine, Alternative-names: , CAS# 475-83-2, Formula: C19H21NO2, MWT: 295.3755, Solubility: DMSO: ≥ 10 mM, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Neuronal Signaling;Neuronal Signaling;GPCR/G Protein, Target: Dopamine Receptor;Dopamine Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Chrysophanol, Alternative-names: Chrysophanic acid, CAS# 481-74-3, Formula: C15H10O4, MWT: 254.2375, Solubility: DMSO: ≥ 10 mM, Clinical_Information: No Development Reported, Pathway: JAK/STAT Signaling;Protein Tyrosine Kinase/RTK, Target: EGFR;EGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
Astragaloside IV, Alternative-names: , CAS# 84687-43-4, Formula: C41H68O14, MWT: 784.9702, Solubility: DMSO: ≥ 390 mg/mL (Need ultrasonic)
, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway;Stem Cell/Wnt;MAPK/ERK Pathway;Metabolic Enzyme/Protease, Target: JNK;ERK;ERK;MMP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Scutellarin, Alternative-names: , CAS# 27740-01-8, Formula: C21H18O12, MWT: 462.3604, Solubility: DMSO: ≥ 10 mM, Clinical_Information: No Development Reported, Pathway: PI3K/Akt/mTOR;JAK/STAT Signaling;Stem Cell/Wnt, Target: Akt;STAT;STAT, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tanshinone I, Alternative-names: Tanshinone A, CAS# 568-73-0, Formula: C18H12O3, MWT: 276.2861, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Metabolic Enzyme/Protease, Target: Phospholipase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Hesperetin, Alternative-names: , CAS# 520-33-2, Formula: C16H14O6, MWT: 302.2787, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| PH-064, Alternative-names: , CAS# 892546-37-1, Formula: C44H58N8O2S2, MWT: 795.1137, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| AZ191, Alternative-names: , CAS# 1594092-37-1, Formula: C24H27N7O, MWT: 429.5175, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: DYRK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Brigatinib, Alternative-names: AP-26113, CAS# 1197953-54-0, Formula: C29H39ClN7O2P, MWT: 584.0924, Solubility: 10 mM in Ethanol, Clinical_Information: Launched, Pathway: Protein Tyrosine Kinase/RTK, Target: ALK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Eliprodil, Alternative-names: SL-820715, CAS# 119431-25-3, Formula: C20H23ClFNO, MWT: 347.8541, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| SKLB4771, Alternative-names: SKLB 4771;SKLB-4771, CAS# 1370256-78-2, Formula: C25H27N7O3S2, MWT: 537.657, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: FLT3, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| TP-0903, Alternative-names: , CAS# 1341200-45-0, Formula: C24H30ClN7O2S, MWT: 516.0587, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Phase 1, Pathway: Protein Tyrosine Kinase/RTK, Target: TAM Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ranirestat, Alternative-names: AS-3201, CAS# 147254-64-6, Formula: C17H11BrFN3O4, MWT: 420.1893, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Metabolic Enzyme/Protease, Target: Aldose Reductase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Clioquinol, Alternative-names: Iodochlorhydroxyquin, CAS# 130-26-7, Formula: C9H5ClINO, MWT: 305.4996, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Anti-infection;Autophagy, Target: Fungal;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| PKC-IN-1, Alternative-names: , CAS# 1046787-18-1, Formula: C25H37FN8O2, MWT: 500.6121, Solubility: DMSO: ≥ 25 mg/mL, Clinical_Information: No Development Reported, Pathway: TGF-beta/Smad;Epigenetics, Target: PKC;PKC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Loxapine (succinate), Alternative-names: , CAS# 27833-64-3, Formula: C22H24ClN3O5, MWT: 445.8961, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| BVT 2733, Alternative-names: , CAS# 376640-41-4, Formula: C17H21ClN4O3S2, MWT: 428.9566, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Tolazoline (hydrochloride), Alternative-names: Imidaline hydrochloride;Benzidazol hydrochloride, CAS# 59-97-2, Formula: C10H13ClN2, MWT: 196.6766, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Tetracaine, Alternative-names: Amethocaine, CAS# 94-24-6, Formula: C15H24N2O2, MWT: 264.3633, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Aminohippurate (sodium), Alternative-names: Sodium p-aminohippurate;p-Aminohippuric acid sodium salt, CAS# 94-16-6, Formula: C9H10N2NaO3+, MWT: 217.1765207, Solubility: DMSO: ≥ 46 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fluphenazine (dihydrochloride), Alternative-names: , CAS# 146-56-5, Formula: C22H28Cl2F3N3OS, MWT: 510.4434, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Diphenidol (hydrochloride), Alternative-names: Difenidol hydrochloride, CAS# 3254-89-5, Formula: C21H28ClNO, MWT: 345.9061, Solubility: DMSO: ≥ 46 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Methacholine (chloride), Alternative-names: Acetyl-β-methylcholine chloride, CAS# 62-51-1, Formula: C8H18ClNO2, MWT: 195.687, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Procainamide (hydrochloride), Alternative-names: , CAS# 614-39-1, Formula: C13H22ClN3O, MWT: 271.7863, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Netilmicin (sulfate), Alternative-names: , CAS# 56391-57-2, Formula: C21H41N5O7 . 5/2 H2O4S , MWT: 720.78, Solubility: H<sub>2</sub>O: ≥ 40 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Octocrylene, Alternative-names: , CAS# 6197-30-4, Formula: C24H27NO2, MWT: 361.4767, Solubility: DMSO: ≥ 130 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Cefotaxime (sodium salt), Alternative-names: Cefotaxim sodium salt, CAS# 64485-93-4, Formula: C16H17N5NaO7S2+, MWT: 478.4547007, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Colistin (sulfate), Alternative-names: Polymyxin E Sulfate, CAS# 1264-72-8, Formula: C52H100N16O17S, MWT: 1253.512, Solubility: H<sub>2</sub>O: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy, Target: Bacterial;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nitrofurantoin, Alternative-names: , CAS# 67-20-9, Formula: C8H6N4O5, MWT: 238.157, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| 1-Docosanol, Alternative-names: Behenyl alcohol, CAS# 661-19-8, Formula: C22H46O, MWT: 326.6, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: HSV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Levobupivacaine (hydrochloride), Alternative-names: (S)-(-)-Bupivacaine monohydrochloride, CAS# 27262-48-2, Formula: C18H29ClN2O, MWT: 324.8887, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: Launched, Pathway: Autophagy;Metabolic Enzyme/Protease, Target: Autophagy;Phospholipase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Cefmenoxime (hydrochloride), Alternative-names: Cefmenoxime hemihydrochloride;SCE-1365 hemihydrochloride, CAS# 75738-58-8, Formula: C16H17N9O5S3 . 1/2 HCl, MWT: 529.79, Solubility: DMSO: < 8.2 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fomepizole, Alternative-names: 4-Methylpyrazole, CAS# 7554-65-6, Formula: C4H6N2, MWT: 82.10384, Solubility: H<sub>2</sub>O: ≥ 146 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Halcinonide, Alternative-names: , CAS# 3093-35-4, Formula: C24H32ClFO5, MWT: 454.9593, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: Launched, Pathway: Stem Cell/Wnt, Target: Smo, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Halobetasol (propionate), Alternative-names: BMY-30056;CGP-14458;Ulobetasol propionate, CAS# 66852-54-8, Formula: C25H31ClF2O5, MWT: 484.9604, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Betaine (hydrochloride), Alternative-names: Betaine chloride, CAS# 590-46-5, Formula: C5H12ClNO2, MWT: 153.6073, Solubility: H<sub>2</sub>O: ≥ 43 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| RI-2, Alternative-names: , CAS# 1417162-36-7, Formula: C21H18Cl2N2O4, MWT: 433.2846, Solubility: DMSO: 15.5 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: RAD51, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Thiamet G, Alternative-names: , CAS# 1009816-48-1, Formula: C9H16N2O4S, MWT: 248.2993, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Motolimod, Alternative-names: VTX-2337;VTX-378, CAS# 926927-61-9, Formula: C28H34N4O2, MWT: 458.5952, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Immunology/Inflammation, Target: Toll-like Receptor (TLR), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Chembridge-5861528, Alternative-names: TCS 5861528, CAS# 332117-28-9, Formula: C19H23N5O3, MWT: 369.4176, Solubility: DMSO: < 9 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: TRP Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Piboserod, Alternative-names: SB-207266, CAS# 152811-62-6, Formula: C22H31N3O2, MWT: 369.5004, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Phase 2, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Piboserod (hydrochloride), Alternative-names: SB-207266 hydrochloride, CAS# 178273-87-5, Formula: C22H32ClN3O2, MWT: 405.9614, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| AFN-1252, Alternative-names: API-1252;Debio 1452, CAS# 620175-39-5, Formula: C22H21N3O3, MWT: 375.4204, Solubility: DMSO: 5.8 mg/mL(Need ultrasonic), Clinical_Information: Phase 2, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SP-420, Alternative-names: , CAS# 911714-45-9, Formula: C16H21NO6S, MWT: 355.406, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Phase 1, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| L-(-)-α-Methyldopa (hydrate), Alternative-names: MK-351 hydrate;Methyldopa hydrate, CAS# 41372-08-1, Formula: C10H16NO5.5, MWT: 238.23744, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Azelaic acid, Alternative-names: Nonanedioic acid, CAS# 123-99-9, Formula: C9H16O4, MWT: 188.2209, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Hydroxyprogesterone caproate, Alternative-names: 17α-Hydroxyprogesterone hexanoate;17α-Hydroxyprogesterone caproate, CAS# 630-56-8, Formula: C27H40O4, MWT: 428.6041, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| TVP1022 (mesylate), Alternative-names: (S)-Rasagiline mesylate;S-PAI mesylate, CAS# 202464-88-8, Formula: C13H17NO3S, MWT: 267.344, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| WIKI4, Alternative-names: , CAS# 838818-26-1, Formula: C29H23N5O3S, MWT: 521.5896, Solubility: DMSO: 6.8 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt, Target: β-catenin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Lemborexant, Alternative-names: E-2006, CAS# 1369764-02-2, Formula: C22H20F2N4O2, MWT: 410.4166, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Phase 3, Pathway: GPCR/G Protein, Target: Orexin Receptor (OX Receptor), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| MC1568, Alternative-names: , CAS# 852475-26-4, Formula: C17H15FN2O3, MWT: 314.311, Solubility: DMSO: 18.5 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| RPR-260243, Alternative-names: , CAS# 668463-35-2, Formula: C28H25F3N2O4, MWT: 510.5043, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Metoclopramide (hydrochloride hydrate), Alternative-names: Metoclopramide monohydrochloride monohydrate, CAS# 54143-57-6, Formula: C14H25Cl2N3O3, MWT: 354.2726, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| EGF816, Alternative-names: Nazartinib, CAS# 1508250-71-2, Formula: C26H31ClN6O2, MWT: 495.0163, Solubility: DMSO: ≥ 242 mg/mL, Clinical_Information: Phase 2, Pathway: JAK/STAT Signaling;Protein Tyrosine Kinase/RTK, Target: EGFR;EGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PT-2385, Alternative-names: , CAS# 1672665-49-4, Formula: C17H12F3NO4S, MWT: 383.3417, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: HIF/HIF Prolyl-Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2mg |
| AZD9496, Alternative-names: , CAS# 1639042-08-2, Formula: C25H25F3N2O2, MWT: 442.4734, Solubility: DMSO: ≥ 104.5 mg/mL, Clinical_Information: Phase 1, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| SB 242084, Alternative-names: , CAS# 181632-25-7, Formula: C21H19ClN4O2, MWT: 394.8542, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SB 242084 (hydrochloride), Alternative-names: , CAS# 1049747-87-6, Formula: C21H21Cl3N4O2, MWT: 467.776, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| AZD9496 (maleate), Alternative-names: , CAS# 1639042-28-6, Formula: C29H29F3N2O6, MWT: 558.5456, Solubility: 10 mM in DMSO, Clinical_Information: Phase 1, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| EGF816 (mesylate), Alternative-names: Nazartinib mesylate, CAS# 1508250-72-3, Formula: C27H35ClN6O5S, MWT: 591.122, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: JAK/STAT Signaling;Protein Tyrosine Kinase/RTK, Target: EGFR;EGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| T338C Src-IN-1, Alternative-names: , CAS# 1351926-90-3, Formula: C17H20N6O2S, MWT: 372.4447, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: Src, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| T338C Src-IN-2, Alternative-names: , CAS# 1351927-00-8, Formula: C17H18FN5O, MWT: 327.3561, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: Src, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Bambuterol (hydrochloride), Alternative-names: KWD-2183;(¡À)-Bambuterol hydrochlorid, CAS# 81732-46-9, Formula: C18H30ClN3O5, MWT: 403.9009, Solubility: DMSO: < 7.6 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Acetohexamide, Alternative-names: , CAS# 968-81-0, Formula: C15H20N2O4S, MWT: 324.3953, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Edrophonium (chloride), Alternative-names: , CAS# 116-38-1, Formula: C10H16ClNO, MWT: 201.6931, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pargyline (hydrochloride), Alternative-names: , CAS# 306-07-0, Formula: C11H14ClN, MWT: 195.6886, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Trimethadione, Alternative-names: 3,5,5,-Trimethyloxazolidine-2,4-dione, CAS# 127-48-0, Formula: C6H9NO3, MWT: 143.1406, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Ponesimod, Alternative-names: ACT-128800, CAS# 854107-55-4, Formula: C23H25ClN2O4S, MWT: 460.9736, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: GPCR/G Protein, Target: LPL Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| NS1643, Alternative-names: , CAS# 448895-37-2, Formula: C15H10F6N2O3, MWT: 380.2419, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Autophagy;Membrane Transporter/Ion Channel, Target: Autophagy;Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Testosterone (undecanoate), Alternative-names: Testosterone undecylate, CAS# 5949-44-0, Formula: C30H48O3, MWT: 456.7003, Solubility: DMSO: 10 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Androgen Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Entrectinib, Alternative-names: NMS-E628;RXDX-101, CAS# 1108743-60-7, Formula: C31H34F2N6O2, MWT: 560.6375, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: Protein Tyrosine Kinase/RTK;Autophagy;Protein Tyrosine Kinase/RTK;Protein Tyrosine Kinase/RTK, Target: ROS;Autophagy;Trk Receptor;ALK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| TVP1022, Alternative-names: (S)-Rasagiline;S-PAI, CAS# 185517-74-2, Formula: C12H13N, MWT: 171.2383, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Proflavine (hemisulfate), Alternative-names: Proflavin hemisulfate;3,6-Diaminoacridine hemisulfate, CAS# 1811-28-5, Formula: C13H11N3 . 1/2 H2O4S, MWT: 258.29, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Anti-infection;Autophagy, Target: Bacterial;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Minaprine, Alternative-names: , CAS# 25905-77-5, Formula: C17H22N4O, MWT: 298.3828, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Minaprine (dihydrochloride), Alternative-names: , CAS# 25953-17-7, Formula: C17H24Cl2N4O, MWT: 371.3047, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Econazole, Alternative-names: (¡À)-Econazol, CAS# 27220-47-9, Formula: C18H15Cl3N2O, MWT: 381.6835, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Iproniazid (phosphate), Alternative-names: , CAS# 305-33-9, Formula: C9H16N3O5P, MWT: 277.214202, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Permethrin, Alternative-names: , CAS# 52645-53-1, Formula: C21H20Cl2O3, MWT: 391.2877, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sulfacetamide (sodium monohydrate), Alternative-names: , CAS# 6209-17-2, Formula: C8H11N2NaO4S, MWT: 254.2387, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ethacridine (lactate monohydrate), Alternative-names: , CAS# 6402-23-9, Formula: C18H23N3O5, MWT: 361.3923, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Zomepirac (sodium salt), Alternative-names: McN-2783-21-98, CAS# 64092-48-4, Formula: C15H13ClNNaO3, MWT: 313.7114, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: PGE synthase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 17-Hydroxyprogesterone, Alternative-names: 17α-Hydroxyprogesterone;17-OHP, CAS# 68-96-2, Formula: C21H30O3, MWT: 330.4611, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Progesterone Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Benzyl alcohol, Alternative-names: Benzenemethanol, CAS# 100-51-6, Formula: C7H8O, MWT: 108.1378, Solubility: DMSO: ≥ 1.8 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Resorcinol (monoacetate), Alternative-names: Acetylresorcinol;Resorcin monoacetate, CAS# 102-29-4, Formula: C8H8O3, MWT: 152.1473, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Hydroxyzine (pamoate), Alternative-names: , CAS# 10246-75-0, Formula: C44H43ClN2O8, MWT: 763.2738, Solubility: DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Triacetin, Alternative-names: Glyceryl triacetate;1,2,3-Triacetoxypropane, CAS# 102-76-1, Formula: C9H14O6, MWT: 218.2039, Solubility: DMSO: ≥ 2.3 mg/mL, Clinical_Information: Phase 2, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| BPR1J-097, Alternative-names: , CAS# 1327167-19-0, Formula: C27H28N6O3S, MWT: 516.6146, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: FLT3, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Bisoctrizole, Alternative-names: , CAS# 103597-45-1, Formula: C41H50N6O2, MWT: 658.8747, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ceftiofur (sodium), Alternative-names: sodium ceftiofur, CAS# 104010-37-9, Formula: C19H16N5NaO7S3, MWT: 545.5444, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ceftriaxone (sodium hydrate), Alternative-names: Ceftriaxone disodium hemiheptahydrate, CAS# 104376-79-6, Formula: C18H25N8Na2O10.5S3 2+, MWT: 663.6118414, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Anethole, Alternative-names: Anise camphor;p-Propenylanisole;Isoestragole, CAS# 104-46-1, Formula: C10H12O, MWT: 148.2017, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Bromperidol, Alternative-names: R-11333, CAS# 10457-90-6, Formula: C21H23BrFNO2, MWT: 420.3152, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Rufloxacin (hydrochloride), Alternative-names: , CAS# 106017-08-7, Formula: C17H19ClFN3O3S, MWT: 399.8675, Solubility: DMSO: 0.0852 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Hexylene glycol, Alternative-names: 2-Methyl-2,4-pentanediol;MPD, CAS# 107-41-5, Formula: C6H14O2, MWT: 118.1742, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Phase 4, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| α-Lipoic Acid, Alternative-names: (±)-α-Lipoic acid;DL-α-Lipoic acid;Thioctic acid, CAS# 1077-28-7, Formula: C8H14O2S2, MWT: 206.3256, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Tilmicosin, Alternative-names: LY-177370;EL-870, CAS# 108050-54-0, Formula: C46H80N2O13, MWT: 869.133, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Bucetin, Alternative-names: 3-Hydroxy-p-butyrophenetidide, CAS# 1083-57-4, Formula: C12H17NO3, MWT: 223.2683, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Resorcinol, Alternative-names: Resorcin;1,3-Benzenediol, CAS# 108-46-3, Formula: C6H6O2, MWT: 110.1106, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Meticrane, Alternative-names: , CAS# 1084-65-7, Formula: C10H13NO4S2, MWT: 275.3445, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Triflupromazine (hydrochloride), Alternative-names: , CAS# 1098-60-8, Formula: C18H20ClF3N2S, MWT: 388.878, Solubility: DMSO: ≥ 27 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;Autophagy, Target: Dopamine Receptor;Dopamine Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Hexahydrocurcumin, Alternative-names: , CAS# 36062-05-2, Formula: C21H26O6, MWT: 374.4276, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Pardoprunox, Alternative-names: SLV-308;DU-126891, CAS# 269718-84-5, Formula: C12H15N3O2, MWT: 233.2664, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: GPCR/G Protein;Neuronal Signaling;GPCR/G Protein;Neuronal Signaling;GPCR/G Protein, Target: Dopamine Receptor;Dopamine Receptor;Adrenergic Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Pyrithioxin, Alternative-names: Pyritinol;Pyridoxine disulfide;Vitamin B6 disulfide, CAS# 1098-97-1, Formula: C16H20N2O4S2, MWT: 368.471, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Chlorophyllin (sodium copper salt), Alternative-names: Chlorophyllin copper sodium complex;Sodium-copper chlorin e6;Chlorophyllin coppered trisodium salt, CAS# 11006-34-1, Formula: C34H31CuN4Na3O6, MWT: 724.1484, Solubility: H<sub>2</sub>O: ≥ 66.66 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Piperazine, Alternative-names: 1,4-Diazacyclohexane;Diethylenediamine;Hexahydropyrazine;Piperazidine, CAS# 110-85-0, Formula: C4H10N2, MWT: 86.1356, Solubility: DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 10-Undecenoic acid, Alternative-names: Undecylenic acid, CAS# 112-38-9, Formula: C11H20O2, MWT: 184.2753, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Orbifloxacin, Alternative-names: CP-104354, CAS# 113617-63-3, Formula: C19H20F3N3O3, MWT: 395.3756, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Propoxur, Alternative-names: , CAS# 114-26-1, Formula: C11H15NO3, MWT: 209.2417, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Bromindione, Alternative-names: Fluidane;Halinone, CAS# 1146-98-1, Formula: C15H9BrO2, MWT: 301.1348, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Chlorindione, Alternative-names: Chlophenadione;Indaliton;G-25766, CAS# 1146-99-2, Formula: C15H9ClO2, MWT: 256.6837, Solubility: DMSO: ≥ 3 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Azaserine, Alternative-names: CN-15757;CI-337;O-Diazoacetyl-L-serine;P-165, CAS# 115-02-6, Formula: C5H7N3O4, MWT: 173.1268, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tolazamide, Alternative-names: U-17835, CAS# 1156-19-0, Formula: C14H21N3O3S, MWT: 311.3998, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Succinylsulfathiazole, Alternative-names: Succinylsulphathiazole, CAS# 116-43-8, Formula: C13H13N3O5S2, MWT: 355.3894, Solubility: DMSO: ≥ 3.9 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dicloralurea, Alternative-names: DCU;Dichlorolurea, CAS# 116-52-9, Formula: C5H6Cl6N2O3, MWT: 354.8307, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Danthron, Alternative-names: Dantron;Chrysazin;1,8-Dihydroxyanthraquinone, CAS# 117-10-2, Formula: C14H8O4, MWT: 240.2109, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: Launched, Pathway: Epigenetics;PI3K/Akt/mTOR, Target: AMPK;AMPK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Anisindione, Alternative-names: , CAS# 117-37-3, Formula: C16H12O3, MWT: 252.2647, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Oxacillin (sodium salt), Alternative-names: , CAS# 1173-88-2, Formula: C19H18N3NaO5S, MWT: 423.4181, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Diatrizoic acid, Alternative-names: Amidotrizoic acid;Diatrizoate, CAS# 117-96-4, Formula: C11H9I3N2O4, MWT: 613.9136, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Hydrastine, Alternative-names: (-)-β-Hydrastine;(1R,9S)-β-Hydrastine, CAS# 118-08-1, Formula: C21H21NO6, MWT: 383.3945, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Homosalate, Alternative-names: Homomenthyl salicylate, CAS# 118-56-9, Formula: C16H22O3, MWT: 262.3441, Solubility: DMSO: ≥ 55 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Octisalate, Alternative-names: Octyl salicylate;2-Ethylhexyl salicylate, CAS# 118-60-5, Formula: C15H22O3, MWT: 250.3334, Solubility: DMSO: ≥ 2.7 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Efloxate, Alternative-names: Angorlisin, CAS# 119-41-5, Formula: C19H16O5, MWT: 324.3273, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Citiolone, Alternative-names: , CAS# 1195-16-0, Formula: C6H9NO2S, MWT: 159.2062, Solubility: DMSO: ≥ 1.4 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Levocarnitine propionate (hydrochloride), Alternative-names: L-Propionylcarnitine chloride;ST-261, CAS# 119793-66-7, Formula: C10H20ClNO4, MWT: 253.7231, Solubility: DMSO: ≥ 2.5 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Gadoteridol, Alternative-names: SQ-32692;Gd-HP-DO3A, CAS# 120066-54-8, Formula: C17H29GdN4O7, MWT: 558.6848, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ethylparaben, Alternative-names: Ethyl parahydroxybenzoate;Ethyl 4-hydroxybenzoate, CAS# 120-47-8, Formula: C9H10O3, MWT: 166.1739, Solubility: DMSO: ≥ 1.6 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Benzyl benzoate, Alternative-names: Benzoic acid benzyl ester, CAS# 120-51-4, Formula: C14H12O2, MWT: 212.2439, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Roxarsone, Alternative-names: , CAS# 121-19-7, Formula: C6H6AsNO6, MWT: 263.0365, Solubility: DMSO: ≥ 2.6 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Amprolium, Alternative-names: , CAS# 121-25-5, Formula: C14H19ClN4, MWT: 278.7805, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Etebenecid, Alternative-names: , CAS# 1213-06-5, Formula: C11H15NO4S, MWT: 257.3061, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ethylvanillin, Alternative-names: , CAS# 121-32-4, Formula: C9H10O3, MWT: 166.1739, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nalfurafine (hydrochloride), Alternative-names: TRK-820 hydrochloride, CAS# 152658-17-8, Formula: C28H33ClN2O5, MWT: 513.025, Solubility: DMSO: 21 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Opioid Receptor;Opioid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Nalfurafine, Alternative-names: TRK-820, CAS# 152657-84-6, Formula: C28H32N2O5, MWT: 476.5641, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Opioid Receptor;Opioid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| TAK-960, Alternative-names: , CAS# 1137868-52-0, Formula: C27H34F3N7O3, MWT: 561.5992, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Phase 1, Pathway: Cell Cycle/DNA Damage, Target: Polo-like Kinase (PLK), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| TAK-960 (hydrochloride), Alternative-names: , CAS# 1137868-96-2, Formula: C27H35ClF3N7O3, MWT: 598.0601096, Solubility: 10 mM in DMSO, Clinical_Information: Phase 1, Pathway: Cell Cycle/DNA Damage, Target: Polo-like Kinase (PLK), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| 6-Benzylaminopurine, Alternative-names: 6-BAP;BA;N6-Benzyladenine;Benzyladenine, CAS# 1214-39-7, Formula: C12H11N5, MWT: 225.2492, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Benzethonium chloride, Alternative-names: , CAS# 121-54-0, Formula: C27H42ClNO2, MWT: 448.0809, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Malathion, Alternative-names: , CAS# 121-75-5, Formula: C10H19O6PS2, MWT: 330.358, Solubility: DMSO: ≥ 3.8 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pidotimod, Alternative-names: , CAS# 121808-62-6, Formula: C9H12N2O4S, MWT: 244.2676, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nitromide, Alternative-names: 3,5-Dinitrobenzamide, CAS# 121-81-3, Formula: C7H5N3O5, MWT: 211.1317, Solubility: DMSO: ≥ 2 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sulfamonomethoxine, Alternative-names: , CAS# 1220-83-3, Formula: C11H12N4O3S, MWT: 280.303, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Sulfanitran, Alternative-names: , CAS# 122-16-7, Formula: C14H13N3O5S, MWT: 335.3351, Solubility: DMSO: ≥ 22 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Protriptyline (hydrochloride), Alternative-names: , CAS# 1225-55-4, Formula: C19H22ClN, MWT: 299.8377, Solubility: DMSO: ≥ 24 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Mefexamide, Alternative-names: , CAS# 1227-61-8, Formula: C15H24N2O3, MWT: 280.3627, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| CDDO-Im, Alternative-names: RTA-403;TP-235;CDDO-Imidazolide, CAS# 443104-02-7, Formula: C34H43N3O3, MWT: 541.7235, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage;NF-κB, Target: PPAR;PPAR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Mexiletine (hydrochloride), Alternative-names: , CAS# 5370-01-4, Formula: C11H18ClNO, MWT: 215.7197, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Milbemycin oxime, Alternative-names: , CAS# 129496-10-2, Formula: C63H88N2O14, MWT: 1097.378, Solubility: DMSO: ≥ 29 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Hydroquinone, Alternative-names: Quinol;1,4-Benzenediol;1,4-Dihydroxybenzene;HQ, CAS# 123-31-9, Formula: C6H6O2, MWT: 110.1106, Solubility: H<sub>2</sub>O: ≥ 50 mg/mL, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 2-Aminoheptane, Alternative-names: 1-Methylhexylamine;2-Heptylamine, CAS# 123-82-0, Formula: C7H17N, MWT: 115.2166, Solubility: DMSO: ≥ 60 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Oxyphencyclimine (hydrochloride), Alternative-names: , CAS# 125-52-0, Formula: C20H29ClN2O3, MWT: 380.9089, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Oxethazaine, Alternative-names: Oxetacaine, CAS# 126-27-2, Formula: C28H41N3O3, MWT: 467.6434, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: HBV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Paromomycin (sulfate), Alternative-names: Aminosidine sulfate;Paromomycin sulfate salt, CAS# 1263-89-4, Formula: C23H47N5O18S, MWT: 713.707, Solubility: DMSO: ≥ 37 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Erythromycin Ethylsuccinate, Alternative-names: Erythromycin ethyl succinate;EES, CAS# 1264-62-6, Formula: C43H75NO16, MWT: 862.0527, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Anti-infection;Autophagy, Target: Bacterial;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Chloramine-T, Alternative-names: , CAS# 127-65-1, Formula: C7H7ClNNaO2S, MWT: 227.6438, Solubility: H<sub>2</sub>O: ≥ 41 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| CEP dipeptide 1, Alternative-names: , CAS# 816432-15-2, Formula: C18H27N3O6, MWT: 381.4235, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
MK-6096, Alternative-names: Filorexant, CAS# 1088991-73-4, Formula: C24H25FN4O2, MWT: 420.4793, Solubility: DMSO: 12.61 mg/mL (Need ultrasonic)
, Clinical_Information: Phase 2, Pathway: GPCR/G Protein, Target: Orexin Receptor (OX Receptor), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
RSV604, Alternative-names: RSV-604, CAS# 676128-63-5, Formula: C22H17FN4O2, MWT: 388.3944, Solubility: DMSO: ≥ 195 mg/mL
, Clinical_Information: Phase 1, Pathway: Anti-infection, Target: RSV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| AMG-47a, Alternative-names: , CAS# 882663-88-9, Formula: C29H28F3N5O2, MWT: 535.5601, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: Src, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SC144, Alternative-names: , CAS# 895158-95-9, Formula: C16H11FN6O, MWT: 322.2965, Solubility: DMSO: 19.5 mg/mL, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: Interleukin Related, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| SC144 (hydrochloride), Alternative-names: , CAS# 917497-70-2, Formula: C16H12ClFN6O, MWT: 358.7575, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: Interleukin Related, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Sulfabenzamide, Alternative-names: N-Sulfanilylbenzamide, CAS# 127-71-9, Formula: C13H12N2O3S, MWT: 276.311, Solubility: DMSO: ≥ 2.9 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Merbromin, Alternative-names: Mercury dibromofluorescein disodium salt, CAS# 129-16-8, Formula: C20H10Br2HgNa2O6, MWT: 752.6674, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Suramin, Alternative-names: , CAS# 145-63-1, Formula: C51H40N6O23S6, MWT: 1297.28, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: P2Y Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Suramin (sodium salt), Alternative-names: Suramin hexasodium salt;BAY-205;NF-060, CAS# 129-46-4, Formula: C51H34N6Na6O23S6, MWT: 1429.171, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL; DMSO: 5.6 mg/mL (Need warming), Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: P2Y Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Piperidolate (hydrochloride), Alternative-names: , CAS# 129-77-1, Formula: C21H26ClNO2, MWT: 359.8896, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Piperidolate, Alternative-names: , CAS# 82-98-4, Formula: C21H25NO2, MWT: 323.4287, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cloxiquine, Alternative-names: 5-Chloro-8-quinolinol;Dermofungin, CAS# 130-16-5, Formula: C9H6ClNO, MWT: 179.603, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection;Anti-infection, Target: Fungal;Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Riboflavin (phosphate sodium), Alternative-names: FMN-Na;Riboflavin 5'-phosphate sodium;Vitamin B2 Phosphate Sodium Salt, CAS# 130-40-5, Formula: C17H20N4NaO9P, MWT: 478.3256, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Thioridazine (hydrochloride), Alternative-names: , CAS# 130-61-0, Formula: C21H27ClN2S2, MWT: 407.0355, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: Phase 4, Pathway: GPCR/G Protein;Neuronal Signaling;Autophagy;Neuronal Signaling;GPCR/G Protein, Target: Dopamine Receptor;Dopamine Receptor;Autophagy;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dioxybenzone, Alternative-names: Benzophenone-8;UV-24, CAS# 131-53-3, Formula: C14H12O4, MWT: 244.2427, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Phthalylsulfacetamide, Alternative-names: , CAS# 131-69-1, Formula: C16H14N2O6S, MWT: 362.3571, Solubility: DMSO: ≥50 mg/mL;, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Trimetazidine (dihydrochloride), Alternative-names: , CAS# 13171-25-0, Formula: C14H24Cl2N2O3, MWT: 339.258, Solubility: DMSO: < 8 mg/mL, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Cresol, Alternative-names: Cresol mixture of isomers;Hydroxytoluene;Tricresol;Methylphenol, CAS# 1319-77-3, Formula: C7H8O, MWT: 108.14, Solubility: DMSO: ≥ 72 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Diphenylpyraline (hydrochloride), Alternative-names: 4-Diphenylmethoxy-1-methylpiperidine hydrochloride, CAS# 132-18-3, Formula: C19H24ClNO, MWT: 317.853, Solubility: H<sub>2</sub>O: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| NS6180, Alternative-names: , CAS# 353262-04-1, Formula: C16H12F3NOS, MWT: 323.3328, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| GW627368, Alternative-names: , CAS# 439288-66-1, Formula: C30H28N2O6S, MWT: 544.6181, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| 4-Nonylphenol polyethoxylate, Alternative-names: 4-Nonylphenol polyethoxylate;Nonoxinol-9, CAS# 26027-38-3, Formula: N/A, MWT: 1000, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Pheniramine (Maleate), Alternative-names: , CAS# 132-20-7, Formula: C20H24N2O4, MWT: 356.4156, Solubility: H<sub>2</sub>O: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cinchophen, Alternative-names: , CAS# 132-60-5, Formula: C16H11NO2, MWT: 249.264, Solubility: DMSO: ≥150 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Dibenzothiophene, Alternative-names: DBT;Diphenylene sulfide, CAS# 132-65-0, Formula: C12H8S, MWT: 184.2569, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Benzydamine (hydrochloride), Alternative-names: , CAS# 132-69-4, Formula: C19H24ClN3O, MWT: 345.8664, Solubility: H<sub>2</sub>O: ≥ 41 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: PGE synthase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Methicillin (sodium salt), Alternative-names: Meticillin sodium, CAS# 132-92-3, Formula: C17H19N2NaO6S, MWT: 402.3973, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 25mg |
| Penicillin V (Potassium), Alternative-names: Phenoxymethylpenicillin potassium salt, CAS# 132-98-9, Formula: C16H17KN2O5S, MWT: 388.4799, Solubility: H<sub>2</sub>O: ≥ 22 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fenoterol, Alternative-names: Th-1165;Phenoterol, CAS# 13392-18-2, Formula: C17H21NO4, MWT: 303.3529, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dicloxacillin (Sodium hydrate), Alternative-names: Dicloxacillin sodium salt monohydrate, CAS# 13412-64-1, Formula: C19H18Cl2N3NaO6S, MWT: 510.3235, Solubility: H<sub>2</sub>O: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| DEET, Alternative-names: Diethyltoluamide;N,N-Diethyl-m-toluamide, CAS# 134-62-3, Formula: C12H17NO, MWT: 191.2695, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Lobeline (hydrochloride), Alternative-names: α-Lobeline hydrochloride;L-Lobeline hydrochloride, CAS# 134-63-4, Formula: C22H28ClNO2, MWT: 373.9162, Solubility: H<sub>2</sub>O: 6 mg/mL (Need ultrasonic), Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: nAChR;nAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pindolol, Alternative-names: , CAS# 13523-86-9, Formula: C14H20N2O2, MWT: 248.3208, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;GPCR/G Protein, Target: Adrenergic Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Hydrocortisone 17-butyrate, Alternative-names: Cortisol 17-butyrate;Hydrocortisone butyrate, CAS# 13609-67-1, Formula: C25H36O6, MWT: 432.5497, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Fendiline (hydrochloride), Alternative-names: , CAS# 13636-18-5, Formula: C23H26ClN, MWT: 351.9122, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Phenazopyridine (hydrochloride), Alternative-names: , CAS# 136-40-3, Formula: C11H12ClN5, MWT: 249.6995, Solubility: DMSO: 8.75 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Hexylresorcinol, Alternative-names: 4-Hexylresorcinol, CAS# 136-77-6, Formula: C12H18O2, MWT: 194.2701, Solubility: DMSO: ≥ 1.8 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Tyrosinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Ascorbyl palmitate, Alternative-names: L-Ascorbic acid 6-hexadecanoate;6-O-Palmitoyl-L-ascorbic acid, CAS# 137-66-6, Formula: C22H38O7, MWT: 414.5329, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Deferoxamine (mesylate), Alternative-names: Desferrioxamine B mesylate;DFOM, CAS# 138-14-7, Formula: C26H52N6O11S, MWT: 656.7897, Solubility: H<sub>2</sub>O: ≥ 33 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;Autophagy, Target: Amyloid-β;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Levofloxacin (hydrate), Alternative-names: Levofloxacin hemihydrate, CAS# 138199-71-0, Formula: C18H20FN3O4 . 0.5H2O, MWT: 370.38, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Mafenide (hydrochloride), Alternative-names: , CAS# 138-37-4, Formula: C7H11ClN2O2S, MWT: 222.6924, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Carzenide, Alternative-names: 4-Sulfamoylbenzoic acid, CAS# 138-41-0, Formula: C7H7NO4S, MWT: 201.1998, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Fexofenadine (hydrochloride), Alternative-names: MDL-16455 hydrochloride;Terfenidine carboxylate hydrochloride, CAS# 153439-40-8, Formula: C32H40ClNO4, MWT: 538.1173, Solubility: DMSO: ≥ 50 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Thiostrepton, Alternative-names: , CAS# 1393-48-2, Formula: C72H85N19O18S5, MWT: 1664.887, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Amoxapine, Alternative-names: CL-67772, CAS# 14028-44-5, Formula: C17H16ClN3O, MWT: 313.7814, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| Nithiamide, Alternative-names: CL-5279;Aminitrozole, CAS# 140-40-9, Formula: C5H5N3O3S, MWT: 187.1765, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Mangafodipir (trisodium), Alternative-names: , CAS# 140678-14-4, Formula: C22H27MnN4Na3O14P2, MWT: 757.3231, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Cyanoacetohydrazide, Alternative-names: Cyanoacetic hydrazide;2-Cyanoacetohydrazide, CAS# 140-87-4, Formula: C3H5N3O, MWT: 99.0913, Solubility: DMSO: ≥ 1.2 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Tiletamine (hydrochloride), Alternative-names: Tiletamin hydrochloride, CAS# 14176-50-2, Formula: C12H18ClNOS, MWT: 259.7954, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Hexetidine, Alternative-names: NSC-17764, CAS# 141-94-6, Formula: C21H45N3, MWT: 339.6021, Solubility: DMSO: ≥ 29 mg/mL, Clinical_Information: Phase 4, Pathway: Anti-infection;Anti-infection, Target: Fungal;Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Hydroquinidine, Alternative-names: Dihydroquinidine;(+)-Hydroquinidine;Hydroconquinine, CAS# 1435-55-8, Formula: C20H26N2O2, MWT: 326.4326, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Dehydrocholate (sodium), Alternative-names: Sodium dehydrocholate, CAS# 145-41-5, Formula: C24H33NaO5, MWT: 424.5056, Solubility: DMSO: ≥ 25 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Chlorindanol, Alternative-names: Clorindanol;7-Chloro-4-indanol, CAS# 145-94-8, Formula: C9H9ClO, MWT: 168.6202, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Selenomethionine, Alternative-names: Seleno-DL-methionine;DL-Selenomethionine, CAS# 1464-42-2, Formula: C5H11NO2Se, MWT: 196.1063, Solubility: H<sub>2</sub>O: 13.66 mg/mL, Clinical_Information: Phase 4, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| U-104, Alternative-names: NSC-213841;MST-104, CAS# 178606-66-1, Formula: C13H12FN3O3S, MWT: 309.3161, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Carbonic Anhydrase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| UK 14,304 (tartrate), Alternative-names: Brimonidine tartrate;AGN190342 tartrate;UK14304 tartrate, CAS# 70359-46-5, Formula: C15H16BrN5O6, MWT: 442.2214, Solubility: DMSO: ≥ 37 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pazufloxacin (mesylate), Alternative-names: T-3762;Pazufloxacin methanesulfonate;Pazufloxacin mesilate, CAS# 163680-77-1, Formula: C17H19FN2O7S, MWT: 414.4054, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Todralazine, Alternative-names: Ecarazine, CAS# 14679-73-3, Formula: C11H12N4O2, MWT: 232.2386, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Oxolinic acid, Alternative-names: , CAS# 14698-29-4, Formula: C13H11NO5, MWT: 261.2301, Solubility: DMSO: < 2.9 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: DNA/RNA Synthesis, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Dinitolmide, Alternative-names: Zoalene, CAS# 148-01-6, Formula: C8H7N3O5, MWT: 225.15828, Solubility: DMSO: ≥ 49 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| 8-Hydroxyquinoline, Alternative-names: , CAS# 148-24-3, Formula: C9H7NO, MWT: 145.158, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pilocarpine (nitrate), Alternative-names: , CAS# 148-72-1, Formula: C11H17N3O5, MWT: 271.26978, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Butacaine, Alternative-names: , CAS# 149-16-6, Formula: C18H30N2O2, MWT: 306.443, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 4-Aminobenzoic acid, Alternative-names: PABA;Vitamin Bx;Vitamin H1, CAS# 150-13-0, Formula: C7H7NO2, MWT: 137.136, Solubility: H<sub>2</sub>O: 6.66 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Ethylenediaminetetraacetic acid (trisodium salt), Alternative-names: EDTA trisodium salt;Trisodium EDTA, CAS# 150-38-9, Formula: C10H13N2Na3O8, MWT: 358.1881, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| TH588, Alternative-names: , CAS# 1609960-31-7, Formula: C13H12Cl2N4, MWT: 295.1672, Solubility: DMSO: 16 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: DNA/RNA Synthesis, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| TH588 (hydrochloride), Alternative-names: , CAS# 1640282-30-9, Formula: C13H13Cl3N4, MWT: 331.6281, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: DNA/RNA Synthesis, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Goserelin (acetate), Alternative-names: ICI-118630 acetate, CAS# 145781-92-6, Formula: C61H88N18O16, MWT: 1329.46242, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: GNRH Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Anagliptin, Alternative-names: SK-0403, CAS# 739366-20-2, Formula: C19H25N7O2, MWT: 383.4475, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Dipeptidyl Peptidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| TH287, Alternative-names: , CAS# 1609960-30-6, Formula: C11H10Cl2N4, MWT: 269.1299, Solubility: DMSO: ≥ 2.6 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: DNA/RNA Synthesis, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| TH287 (hydrochloride), Alternative-names: , CAS# 1638211-05-8, Formula: C11H11Cl3N4, MWT: 305.5909, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: DNA/RNA Synthesis, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SW033291, Alternative-names: , CAS# 459147-39-8, Formula: C21H20N2OS3, MWT: 412.5913, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: 15-PGDH, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| SR9243, Alternative-names: , CAS# 1613028-81-1, Formula: C31H32BrNO4S2, MWT: 626.6241, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: LXR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Methenolone (acetate), Alternative-names: Metenolone acetate, CAS# 434-05-9, Formula: C22H32O3, MWT: 344.4877, Solubility: DMSO: ≥ 3.6 mg/mL; DMSO: < 8.6 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Androgen Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Ceftibuten (dihydrate), Alternative-names: Sch-39720 dihydrate, CAS# 118081-34-8, Formula: C15H18N4O8S2, MWT: 446.4554, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ceftriaxone (sodium salt), Alternative-names: Disodium ceftriaxone, CAS# 74578-69-1, Formula: C18H18N8Na2O7S3 2+, MWT: 600.5583614, Solubility: H<sub>2</sub>O: ≥ 40 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Fusidic acid (sodium salt), Alternative-names: Sodium fusidate;SQ-16360, CAS# 751-94-0, Formula: C31H47NaO6, MWT: 538.691, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Balsalazide (sodium hydrate), Alternative-names: Balsalazide disodium dihydrate, CAS# 150399-21-6, Formula: C17H17N3Na2O8, MWT: 437.3117, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Immunology/Inflammation;JAK/STAT Signaling;Stem Cell/Wnt, Target: Interleukin Related;STAT;STAT, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Halothane, Alternative-names: , CAS# 151-67-7, Formula: C2HBrClF3, MWT: 197.3815, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Edoxudine, Alternative-names: EUDR, CAS# 15176-29-1, Formula: C11H16N2O5, MWT: 256.2551, Solubility: DMSO: ≥125 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Quinestrol, Alternative-names: W-3566, CAS# 152-43-2, Formula: C25H32O2, MWT: 364.5204, Solubility: DMSO: ≥ 24 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Flurandrenolide, Alternative-names: Fludroxycortide;Flurandrenolone, CAS# 1524-88-5, Formula: C24H33FO6, MWT: 436.5136, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Acenocoumarol, Alternative-names: , CAS# 152-72-7, Formula: C19H15NO6, MWT: 353.3255, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Etosalamide, Alternative-names: Ethosalamide, CAS# 15302-15-5, Formula: C11H15NO3, MWT: 209.2417, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Trapidil, Alternative-names: AR-12008, CAS# 15421-84-8, Formula: C10H15N5, MWT: 205.2596, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Protein Tyrosine Kinase/RTK, Target: PDGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Almotriptan, Alternative-names: , CAS# 154323-57-6, Formula: C17H25N3O2S, MWT: 335.4643, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Molindone (hydrochloride), Alternative-names: EN-1733A, CAS# 15622-65-8, Formula: C16H25ClN2O2, MWT: 312.8349, Solubility: DMSO: 17.5 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Phenelzine, Alternative-names: , CAS# 51-71-8, Formula: C8H12N2, MWT: 136.1943, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Phenelzine (sulfate), Alternative-names: , CAS# 156-51-4, Formula: C8H14N2O4S, MWT: 234.2728, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Sulpiride, Alternative-names: , CAS# 15676-16-1, Formula: C15H23N3O4S, MWT: 341.4258, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Chloralose, Alternative-names: α-Chloralose, CAS# 15879-93-3, Formula: C8H11Cl3O6, MWT: 309.5284, Solubility: DMSO: ≥ 46 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Vincamine, Alternative-names: , CAS# 1617-90-9, Formula: C21H26N2O3, MWT: 354.4427, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Esomeprazole (potassium salt), Alternative-names: (S)-Omeprazole potassium, CAS# 161796-84-5, Formula: C17H18KN3O3S, MWT: 383.5064, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Proton Pump, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Dimesna, Alternative-names: BNP-7787, CAS# 16208-51-8, Formula: C4H8Na2O6S4, MWT: 326.3423, Solubility: DMSO: < 9.4 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Mexenone, Alternative-names: , CAS# 1641-17-4, Formula: C15H14O3, MWT: 242.2699, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pantoprazole (sodium hydrate), Alternative-names: SKF96022 sodium hydrate, CAS# 164579-32-2, Formula: C16H15F2N3O4S . 3/2H2 O . Na, MWT: 433.38, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Proton Pump, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| DL-Panthenol, Alternative-names: DL-Pantothenol;DL-Pantothenyl alcohol, CAS# 16485-10-2, Formula: C9H19NO4, MWT: 205.2515, Solubility: DMSO: ≥ 46 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Digoxigenin, Alternative-names: Lanadigenin, CAS# 1672-46-4, Formula: C23H34O5, MWT: 390.5131, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Adelmidrol, Alternative-names: , CAS# 1675-66-7, Formula: C13H26N2O4, MWT: 274.3565, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: Phase 3, Pathway: NF-κB, Target: NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Hydroxysafflor yellow A, Alternative-names: Safflomin A;HSYA, CAS# 78281-02-4, Formula: C27H32O16, MWT: 612.5334, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Liraglutide, Alternative-names: , CAS# 204656-20-2, Formula: C172H265N43O51, MWT: 3751.202, Solubility: H<sub>2</sub>O; PBS, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucagon Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| Pantethine, Alternative-names: D-Pantethine;LBF disulfide, CAS# 16816-67-4, Formula: C22H42N4O8S2, MWT: 554.7209, Solubility: DMSO: ≥ 30 mg/mL; H<sub>2</sub>O: ≥ 80 mg/mL, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Danazol, Alternative-names: , CAS# 17230-88-5, Formula: C22H27NO2, MWT: 337.4553, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Androgen Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Lanatoside C, Alternative-names: , CAS# 17575-22-3, Formula: C49H76O20, MWT: 985.1157, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Anisodamine, Alternative-names: 6-Hydroxyhyoscyamine, CAS# 55869-99-3, Formula: C17H23NO4, MWT: 305.3688, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dropropizine, Alternative-names: (¡À)-Dropropizine;UCB-196, CAS# 17692-31-8, Formula: C13H20N2O2, MWT: 236.3101, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Metergoline, Alternative-names: , CAS# 17692-51-2, Formula: C25H29N3O2, MWT: 403.5167, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Vanitiolide, Alternative-names: Vanitiolid, CAS# 17692-71-6, Formula: C12H15NO3S, MWT: 253.3174, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Clorgiline (hydrochloride), Alternative-names: Clorgyline hydrochloride, CAS# 17780-75-5, Formula: C13H16Cl3NO, MWT: 308.6312, Solubility: DMSO: ≥ 100mg/mL, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Levobunolol (hydrochloride), Alternative-names: l-Bunolol hydrochloride, CAS# 27912-14-7, Formula: C17H26ClNO3, MWT: 327.8463, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Decoquinate, Alternative-names: , CAS# 18507-89-6, Formula: C24H35NO5, MWT: 417.5384, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Salbutamol, Alternative-names: Albuterol;AH-3365, CAS# 18559-94-9, Formula: C13H21NO3, MWT: 239.3107, Solubility: DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| L-Cysteine methyl ester (hydrochloride), Alternative-names: , CAS# 18598-63-5, Formula: C4H10ClNO2S, MWT: 171.6457, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Ambroxol, Alternative-names: , CAS# 18683-91-5, Formula: C13H18Br2N2O, MWT: 378.1028, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ftaxilide, Alternative-names: , CAS# 19368-18-4, Formula: C16H15NO3, MWT: 269.2952, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| CC-223, Alternative-names: , CAS# 1228013-30-6, Formula: C21H27N5O3, MWT: 397.4708, Solubility: DMSO: ≥ 27 mg/mL, Clinical_Information: Phase 2, Pathway: PI3K/Akt/mTOR, Target: mTOR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CC-115, Alternative-names: , CAS# 1228013-15-7, Formula: C16H16N8O, MWT: 336.3512, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Phase 2, Pathway: PI3K/Akt/mTOR;Cell Cycle/DNA Damage;PI3K/Akt/mTOR, Target: DNA-PK;DNA-PK;mTOR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Aminoguanidine (hydrochloride), Alternative-names: Pimagedine hydrochloride;GER-11;Aminoguanidinium chloride, CAS# 1937-19-5, Formula: CH7ClN4, MWT: 110.5461, Solubility: H<sub>2</sub>O: ≥ 43 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Oxolamine (citrate), Alternative-names: SKF-9976 citrate;AF-438 citrate, CAS# 1949-20-8, Formula: C20H27N3O8, MWT: 437.4437, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Piromidic acid, Alternative-names: , CAS# 19562-30-2, Formula: C14H16N4O3, MWT: 288.3018, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Idramantone, Alternative-names: Kemantane;5-Hydroxy-2-adamantanone, CAS# 20098-14-0, Formula: C10H14O2, MWT: 166.217, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Chlorazanil (hydrochloride), Alternative-names: , CAS# 2019-25-2, Formula: C9H9Cl2N5, MWT: 258.1073, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Clofazimine, Alternative-names: , CAS# 2030-63-9, Formula: C27H22Cl2N4, MWT: 473.3964, Solubility: DMSO: < 6.4 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Carsalam, Alternative-names: Carbonylsalicylamide;2H-1,3-Benzoxazine-2,4(3H)-dione, CAS# 2037-95-8, Formula: C8H5NO3, MWT: 163.1302, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pasiniazid, Alternative-names: Paraniazide;Pasiniazide;Isonicotinic acid hydrazide p-aminosalicylate, CAS# 2066-89-9, Formula: C13H14N4O4, MWT: 290.2747, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Mitiglinide (calcium hydrate), Alternative-names: KAD-1229 calcium hydrate;S-21403 calcium hydrate, CAS# 207844-01-7, Formula: C19H25NO3 . 1/2 Ca . H2O, MWT: 353.46, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Digoxin, Alternative-names: 12β-Hydroxydigitoxin, CAS# 20830-75-5, Formula: C41H64O14, MWT: 780.9385, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Na+/K+ ATPase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Gemifloxacin (mesylate), Alternative-names: SB-265805S;LB-20304a, CAS# 210353-53-0, Formula: C19H24FN5O7S, MWT: 485.4866, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Flumethasone, Alternative-names: Flumetasone, CAS# 2135-17-3, Formula: C22H28F2O5, MWT: 410.4515, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Lofexidine (hydrochloride), Alternative-names: Baq-168;MDL-14042, CAS# 21498-08-8, Formula: C11H13Cl3N2O, MWT: 295.5927, Solubility: DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Iotalamic acid, Alternative-names: Iothalamic acid, CAS# 2276-90-6, Formula: C11H9I3N2O4, MWT: 613.9136, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Famprofazone, Alternative-names: , CAS# 22881-35-2, Formula: C24H31N3O, MWT: 377.5224, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Carbetapentane (citrate), Alternative-names: Pentoxyverine citrate, CAS# 23142-01-0, Formula: C26H39NO10, MWT: 525.5886, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Procodazole, Alternative-names: Propazol;2-Benzimidazolepropionic acid, CAS# 23249-97-0, Formula: C10H10N2O2, MWT: 190.1986, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Nefopam (hydrochloride), Alternative-names: Fenazoxine hydrochloride, CAS# 23327-57-3, Formula: C17H20ClNO, MWT: 289.7998, Solubility: H<sub>2</sub>O: 14 mg/mL, Clinical_Information: Launched, Pathway: Stem Cell/Wnt, Target: β-catenin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Benfluorex (hydrochloride), Alternative-names: , CAS# 23642-66-2, Formula: C19H21ClF3NO2, MWT: 387.8238, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Levosulpiride, Alternative-names: S-(-)-Sulpiride, CAS# 23672-07-3, Formula: C15H23N3O4S, MWT: 341.4258, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 6α-Methylprednisolone 21-hemisuccinate (sodium salt), Alternative-names: Methylprednisolone sodium succinate;6-Methylprednisolone succinate sodium, CAS# 2375-03-3, Formula: C26H33NaO8, MWT: 496.5252, Solubility: DMSO: ≥ 25 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| MF498, Alternative-names: , CAS# 915191-42-3, Formula: C32H33N3O7S, MWT: 603.6853, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| MK2-IN-1 (hydrochloride), Alternative-names: MK2 Inhibitor, CAS# 1314118-94-9, Formula: C27H26Cl2N4O2, MWT: 509.4269, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway, Target: MAPKAPK2 (MK2), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Glutaminase C-IN-1, Alternative-names: 968, CAS# 311795-38-7, Formula: C27H27BrN2O, MWT: 475.4201, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| BPTES, Alternative-names: , CAS# 314045-39-1, Formula: C24H24N6O2S3, MWT: 524.6813, Solubility: DMSO: 52 mg/mL (Need ultrasonic and warming), Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| DC_517, Alternative-names: , CAS# 500017-70-9, Formula: C33H35N3O2, MWT: 505.6499, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: DNA Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| GDC-0810, Alternative-names: ARN-810;Brilanestrant, CAS# 1365888-06-7, Formula: C26H20ClFN2O2, MWT: 446.9006, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Phase 2, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| MK-0354, Alternative-names: , CAS# 851776-28-8, Formula: C7H8N6, MWT: 176.1786, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: GPR109A, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Quinacrine (dihydrochloride), Alternative-names: Mepacrine dihydrochloride;SN-390, CAS# 69-05-6, Formula: C23H32Cl3N3O, MWT: 472.8787, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: Phase 2, Pathway: Autophagy;Metabolic Enzyme/Protease, Target: Autophagy;Phospholipase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Mavatrep, Alternative-names: JNJ-39439335, CAS# 956274-94-5, Formula: C25H21F3N2O, MWT: 422.4423, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: Phase 1, Pathway: Membrane Transporter/Ion Channel, Target: TRP Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| EPZ011989, Alternative-names: , CAS# 1598383-40-4, Formula: C35H51N5O4, MWT: 605.8105, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Epigenetics, Target: Histone Methyltransferase;Epigenetic Reader Domain, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SJG-136, Alternative-names: NSC-694501, CAS# 232931-57-6, Formula: C31H32N4O6, MWT: 556.609, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Cell Cycle/DNA Damage, Target: DNA Alkylator/Crosslinker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| SKF 82958, Alternative-names: (¡À)-SKF 82958;Chloro-AP, CAS# 80751-65-1, Formula: C19H20ClNO2, MWT: 329.8206, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| SKF-82958 (hydrobromide), Alternative-names: (±)-SKF 82958 hydrobromide;Chloro-APB hydrobromid, CAS# 74115-01-8, Formula: C19H21BrClNO2, MWT: 410.7325, Solubility: DMSO: ≥ 102.5 mg/mL; H<sub>2</sub>O: < 6 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Presatovir, Alternative-names: GS-5806, CAS# 1353625-73-6, Formula: C24H30ClN7O3S, MWT: 532.0581, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Anti-infection, Target: RSV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SH-4-54, Alternative-names: , CAS# 1456632-40-8, Formula: C29H27F5N2O5S, MWT: 610.5921, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: JAK/STAT Signaling;Stem Cell/Wnt, Target: STAT;STAT, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2mg |
| Tandospirone (citrate), Alternative-names: SM-3997 citrate, CAS# 112457-95-1, Formula: C27H37N5O9, MWT: 575.6108, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| IDO-IN-1, Alternative-names: , CAS# 914638-30-5, Formula: C9H7BrFN5O2, MWT: 316.0866, Solubility: DMSO: ≥ 682 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Indoleamine 2,3-Dioxygenase (IDO), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2mg |
| D-Lys(Z)-Pro-Arg-pNA (diacetate), Alternative-names: Spectrozyme PCa;H-DLys (Cbo)-Pro-Arg-pNA diacetate;Chromozym Pca diacetate, CAS# 108963-70-8, Formula: C35H51N9O11, MWT: 773.8331, Solubility: H<sub>2</sub>O: ≥ 8.88 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| KHK-IN-1, Alternative-names: ketohexokinase inhibitor, CAS# 1303469-70-6, Formula: C21H26N8S, MWT: 422.5497, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
KHK-IN-1 (hydrochloride), Alternative-names: ketohexokinase inhibitor
, CAS# 1303470-48-5, Formula: C21H27ClN8S, MWT: 459.0107, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cefradine, Alternative-names: Cephradine;SQ-11436, CAS# 38821-53-3, Formula: C16H19N3O4S, MWT: 349.4048, Solubility: DMSO: ≥ 3.6 mg/mL; DMSO: < 9 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Imidazolidinyl urea, Alternative-names: , CAS# 39236-46-9, Formula: C11H16N8O8, MWT: 388.2935, Solubility: DMSO: ≥ 4 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Sulisobenzone, Alternative-names: Benzophenone-4, CAS# 4065-45-6, Formula: C14H12O6S, MWT: 308.3065, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Luteolin, Alternative-names: Luteolol;Digitoflavone;Flacitran;Luteoline, CAS# 491-70-3, Formula: C15H10O6, MWT: 286.2363, Solubility: DMSO: ≥ 37 mg/mL, Clinical_Information: Phase 2, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| D-Pantothenic acid (hemicalcium salt), Alternative-names: Calcium D-pantothenate;Vitamin B5 calcium salt;Calcium pantothenate, CAS# 137-08-6, Formula: C9H16NO5 . 1/2 Ca, MWT: 238.27, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Nandrolone decanoate, Alternative-names: 19-Nortestosterone decanoate, CAS# 360-70-3, Formula: C28H44O3, MWT: 428.6472, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| Pyrithioxin (dihydrochloride), Alternative-names: Pyritinol dihydrochloride;Pyridoxine disulfide dihydrochloride;Vitamin B6 disulfide dihydrochloride, CAS# 10049-83-9, Formula: C16H22Cl2N2O4S2, MWT: 441.3929, Solubility: H<sub>2</sub>O: ≥ 41 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Spautin-1, Alternative-names: , CAS# 1262888-28-7, Formula: C15H11F2N3, MWT: 271.2647, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Nicotinic acid N-oxide, Alternative-names: , CAS# 2398-81-4, Formula: C6H5NO3, MWT: 139.1088, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Dexchlorpheniramine (maleate), Alternative-names: S-(+)-Chlorpheniramine maleate salt, CAS# 2438-32-6, Formula: C20H23ClN2O4, MWT: 390.8606, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Terpin (hydrate), Alternative-names: Terpin monohydrate;cis-Terpin hydrate, CAS# 2451-01-6, Formula: C10H22O3, MWT: 190.27988, Solubility: H<sub>2</sub>O: ≥ 1.9 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Clindamycin (phosphate), Alternative-names: Clindamycin 2-dihydrogen phosphate;Clindamycin 2-phosphate;U-28508, CAS# 24729-96-2, Formula: C18H34ClN2O8PS, MWT: 504.9629, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: Bacterial;Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Aceglutamide, Alternative-names: α-N-Acetyl-L-glutamine;N2-Acetylglutamine, CAS# 2490-97-3, Formula: C7H12N2O4, MWT: 188.1812, Solubility: DMSO: 13 mg/mL, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Butylhydroxyanisole, Alternative-names: Butylated hydroxyanisole;BHA;E320, CAS# 25013-16-5, Formula: C11H16O2, MWT: 180.24, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Antazoline (hydrochloride), Alternative-names: Phenazoline hydrochloride, CAS# 2508-72-7, Formula: C17H20ClN3, MWT: 301.8138, Solubility: DMSO: ≥ 53 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tyloxapol, Alternative-names: Triton WR1339, CAS# 25301-02-4, Formula: (C15H21O(C2H4O)m)n, MWT: 1000, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Molsidomine, Alternative-names: SIN-10;Morsydomine, CAS# 25717-80-0, Formula: C9H14N4O4, MWT: 242.2319, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| DL-Xylose, Alternative-names: (±)-Xylos, CAS# 25990-60-7, Formula: C5H10O5, MWT: 150.1299, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Lasalocid, Alternative-names: Antibiotic X-537A;Lasalocid-A;X-537A;Ionophore X-537A, CAS# 25999-31-9, Formula: C34H54O8, MWT: 590.7878, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection;Autophagy, Target: Bacterial;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Phenothrin, Alternative-names: Sumithrin, CAS# 26002-80-2, Formula: C23H26O3, MWT: 350.4507, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Morantel (tartrate), Alternative-names: , CAS# 26155-31-7, Formula: C16H22N2O6S, MWT: 370.4207, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ethamsylate, Alternative-names: , CAS# 2624-44-4, Formula: C10H17NO5S, MWT: 263.3107, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fosfomycin (calcium), Alternative-names: Phosphomycin calcium salt;phosphonomycin calcium salt, CAS# 26016-98-8, Formula: C3H5CaO4P, MWT: 176.1212, Solubility: H<sub>2</sub>O: 3.33 mg/mL; DMSO: < 2 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Medrysone, Alternative-names: HMS;6α-Methyl-11β-hydroxyprogesterone, CAS# 2668-66-8, Formula: C22H32O3, MWT: 344.4877, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Penfluridol, Alternative-names: R-16341, CAS# 26864-56-2, Formula: C28H27ClF5NO, MWT: 523.9651, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Autophagy, Target: Calcium Channel;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Cefazolin (sodium), Alternative-names: Sodium cefazolin;Sodium cephazolin, CAS# 27164-46-1, Formula: C14H13N8NaO4S3, MWT: 476.489, Solubility: H<sub>2</sub>O: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Suxibuzone, Alternative-names: , CAS# 27470-51-5, Formula: C24H26N2O6, MWT: 438.4731, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Tilorone (dihydrochloride), Alternative-names: , CAS# 27591-69-1, Formula: C25H36Cl2N2O3, MWT: 483.4709, Solubility: H<sub>2</sub>O: ≥ 28 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: HIF/HIF Prolyl-Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| TG6-10-1, Alternative-names: , CAS# 1415716-58-3, Formula: C23H23F3N2O4, MWT: 448.4349, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Neuronal Signaling;GPCR/G Protein, Target: Prostaglandin Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Amitifadine (hydrochloride), Alternative-names: DOV-21947 hydrochloride;EB-1010 hydrochloride, CAS# 410074-74-7, Formula: C11H12Cl3N, MWT: 264.5787, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: GPCR/G Protein;Neuronal Signaling;Neuronal Signaling;GPCR/G Protein, Target: Dopamine Receptor;Dopamine Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Phenytoin (sodium), Alternative-names: 5,5-Diphenylhydantoin sodium salt, CAS# 630-93-3, Formula: C15H11N2NaO2, MWT: 274.2498, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Ethynodiol (diacetate), Alternative-names: Ethynodiol acetate, CAS# 297-76-7, Formula: C24H32O4, MWT: 384.5085, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Progesterone Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Secnidazole, Alternative-names: RP-14539;PM-185184, CAS# 3366-95-8, Formula: C7H11N3O3, MWT: 185.1805, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Prednisolone (21-acetate), Alternative-names: , CAS# 52-21-1, Formula: C23H30O6, MWT: 402.4807, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| Pramocaine (hydrochloride), Alternative-names: Pramoxine hydrochloride, CAS# 637-58-1, Formula: C17H28ClNO3, MWT: 329.8621, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| A-366, Alternative-names: , CAS# 1527503-11-2, Formula: C19H27N3O2, MWT: 329.4366, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Gliquidone, Alternative-names: , CAS# 33342-05-1, Formula: C27H33N3O6S, MWT: 527.6324, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Acetylleucine, Alternative-names: N-Acetyl-DL-leucine, CAS# 99-15-0, Formula: C8H15NO3, MWT: 173.2096, Solubility: H<sub>2</sub>O: 13.33 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Oxidopamine (hydrochloride), Alternative-names: 6-Hydroxydopamine hydrochloride;6-OHDA hydrochloride, CAS# 28094-15-7, Formula: C8H12ClNO3, MWT: 205.6388, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Antimonyl (potassium tartrate trihydrate), Alternative-names: Potassium antimonyl tartrate trihydrate;Tartar emetic, CAS# 28300-74-5, Formula: C8H4O12Sb2 . 3H2O . 2K, MWT: 667.87, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Modaline (sulfate), Alternative-names: , CAS# 2856-75-9, Formula: C10H17N3O4S, MWT: 275.3247, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cinoctramide, Alternative-names: , CAS# 28598-08-5, Formula: C19H27NO4, MWT: 333.422, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Cinoxacin, Alternative-names: Compound 64716, CAS# 28657-80-9, Formula: C12H10N2O5, MWT: 262.2182, Solubility: DMSO: < 5.2 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| N-Acetyl-DL-phenylalanine, Alternative-names: Afalanine, CAS# 2901-75-9, Formula: C11H13NO3, MWT: 207.2258, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Prednisolone (hemisuccinate), Alternative-names: Prednisolone 21-hemisuccinate, CAS# 2920-86-7, Formula: C25H32O8, MWT: 460.5168, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Clopidol, Alternative-names: WR-61112, CAS# 2971-90-6, Formula: C7H7Cl2NO, MWT: 192.0426, Solubility: DMSO: < 7.4 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cinnarizine, Alternative-names: , CAS# 298-57-7, Formula: C26H28N2, MWT: 368.5139, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein;Membrane Transporter/Ion Channel, Target: Histamine Receptor;Histamine Receptor;Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Gluconate (Calcium), Alternative-names: Calcium D-gluconate;Gluconic acid hemicalcium salt, CAS# 299-28-5, Formula: C12H24CaO14+2, MWT: 432.3875, Solubility: H<sub>2</sub>O: 10 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fenchlorphos, Alternative-names: , CAS# 299-84-3, Formula: C8H8Cl3O3PS, MWT: 321.5451, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Wy-14643, Alternative-names: Pirinixic acid, CAS# 50892-23-4, Formula: C14H14ClN3O2S, MWT: 323.7979, Solubility: DMSO: 15 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage;NF-κB, Target: PPAR;PPAR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Isomangiferin, Alternative-names: , CAS# 24699-16-9, Formula: C19H18O11, MWT: 422.3396, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Mangiferin, Alternative-names: , CAS# 4773-96-0, Formula: C19H18O11, MWT: 422.3396, Solubility: DMSO: ≥ 10 mM; DMSO: < 8 mg/mL, Clinical_Information: No Development Reported, Pathway: NF-κB, Target: NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Cercosporamide, Alternative-names: (-)-Cercosporamide, CAS# 131436-22-1, Formula: C16H13NO7, MWT: 331.2769, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection;MAPK/ERK Pathway, Target: Fungal;MNK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500ug |
| MPI-0479605, Alternative-names: , CAS# 1246529-32-7, Formula: C22H29N7O, MWT: 407.512, Solubility: DMSO: 11 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage;Cytoskeleton;Cytoskeleton;Cell Cycle/DNA Damage, Target: Mps1;Mps1;Kinesin;Kinesin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| BD-1047 (dihydrobromide), Alternative-names: , CAS# 138356-21-5, Formula: C13H22Br2Cl2N2, MWT: 437.0412, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Sigma Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| SR9011, Alternative-names: , CAS# 1379686-29-9, Formula: C23H31ClN4O3S, MWT: 479.0352, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SR9009, Alternative-names: , CAS# 1379686-30-2, Formula: C20H24ClN3O4S, MWT: 437.9402, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| RAD140, Alternative-names: , CAS# 1182367-47-0, Formula: C20H16ClN5O2, MWT: 393.82634, Solubility: 10 mM in DMSO, Clinical_Information: Phase 1, Pathway: Others, Target: Androgen Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Flibanserin, Alternative-names: BIMT-17;BIMT-17BS, CAS# 167933-07-5, Formula: C20H21F3N4O, MWT: 390.4022, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PQR309, Alternative-names: Bimiralisib, CAS# 1225037-39-7, Formula: C17H20F3N7O2, MWT: 411.3816, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: PI3K/Akt/mTOR;PI3K/Akt/mTOR, Target: PI3K;mTOR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2mg |
| BI605906, Alternative-names: , CAS# 960293-88-3, Formula: C17H22F2N4O3S2, MWT: 432.5084, Solubility: DMSO: ≥ 29 mg/mL, Clinical_Information: No Development Reported, Pathway: NF-κB, Target: IKK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Betamipron, Alternative-names: N-Benzoyl-β-alanine;CS-443, CAS# 3440-28-6, Formula: C10H11NO3, MWT: 193.1992, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Climbazole, Alternative-names: BAY-e 6975, CAS# 38083-17-9, Formula: C15H17ClN2O2, MWT: 292.7607, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| p-Phenylene diisothiocyanate, Alternative-names: 1,4-Diisothiocyanatobenzene;Bitoscanate;PDITC, CAS# 4044-65-9, Formula: C8H4N2S2, MWT: 192.2608, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sulfaguanidine, Alternative-names: , CAS# 57-67-0, Formula: C7H10N4O2S, MWT: 214.2449, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 4-Chloro-3-methylphenol, Alternative-names: 4-Chloro-m-cresol;PCMC;Chlorocresol, CAS# 59-50-7, Formula: C7H7ClO, MWT: 142.5829, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Mulberroside A, Alternative-names: , CAS# 102841-42-9, Formula: C26H32O14, MWT: 568.5239, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation;Apoptosis;Metabolic Enzyme/Protease, Target: Interleukin Related;TNF-alpha;Tyrosinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| C-7280948, Alternative-names: , CAS# 587850-67-7, Formula: C14H16N2O2S, MWT: 276.354, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Verinurad, Alternative-names: , CAS# 1352792-74-5, Formula: C20H16N2O2S, MWT: 348.4182, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: URAT1, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Aklomide, Alternative-names: 2-Chloro-4-nitrobenzamide, CAS# 3011-89-0, Formula: C7H5ClN2O3, MWT: 200.5792, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Chlormadinone (acetate), Alternative-names: , CAS# 302-22-7, Formula: C23H29ClO4, MWT: 404.927, Solubility: DMSO: ≥ 4.5 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Progesterone Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Etamivan, Alternative-names: Ethamivan;N,N-Diethylvanillamide, CAS# 304-84-7, Formula: C12H17NO3, MWT: 223.2683, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pargyline, Alternative-names: , CAS# 555-57-7, Formula: C11H13N, MWT: 159.2276, Solubility: DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Fenaclon, Alternative-names: , CAS# 306-20-7, Formula: C11H14ClNO, MWT: 211.688, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Hydroxyamphetamine, Alternative-names: 4-Hydroxyamphetamine, CAS# 103-86-6, Formula: C9H13NO, MWT: 151.2056, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Midodrine, Alternative-names: (¡À)-Midodrin, CAS# 42794-76-3, Formula: C12H18N2O4, MWT: 254.2823, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Midodrine (hydrochloride), Alternative-names: (¡À)-Midodrine hydrochlorid, CAS# 43218-56-0, Formula: C12H19ClN2O4, MWT: 290.7433, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Estradiol (cypionate), Alternative-names: , CAS# 313-06-4, Formula: C26H36O3, MWT: 396.5622, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Pimethixene, Alternative-names: Pimetixene, CAS# 314-03-4, Formula: C19H19NS, MWT: 293.4259, Solubility: DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein;Neuronal Signaling, Target: Histamine Receptor;Histamine Receptor;AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Evans Blue, Alternative-names: Direct Blue 53;C.I. 23860, CAS# 314-13-6, Formula: C34H24N6Na4O14S4, MWT: 960.8052, Solubility: DMSO: 6.4 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Hydroxyhexamide, Alternative-names: (¡À)-Hydroxyhexamid, CAS# 3168-01-2, Formula: C15H22N2O4S, MWT: 326.4112, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Indoprofen, Alternative-names: (±)-Indoprofe, CAS# 31842-01-0, Formula: C17H15NO3, MWT: 281.3059, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cefadroxil, Alternative-names: BL-S 578, CAS# 50370-12-2, Formula: C16H17N3O5S, MWT: 363.3883, Solubility: H<sub>2</sub>O: < 8 mg/mL; DMSO: < 4 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Histamine, Alternative-names: Ergamine, CAS# 51-45-6, Formula: C5H9N3, MWT: 111.1451, Solubility: H<sub>2</sub>O: ≥ 34 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Neostigmine (methyl sulfate), Alternative-names: , CAS# 51-60-5, Formula: C13H22N2O6S, MWT: 334.3886, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Bronopol, Alternative-names: BNPD;BNPK, CAS# 52-51-7, Formula: C3H6BrNO4, MWT: 199.988, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Clofibric acid, Alternative-names: Chlorofibrinic acid, CAS# 882-09-7, Formula: C10H11ClO3, MWT: 214.6455, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tetrahydroxyquinone, Alternative-names: Tetrahydroxy-1,4-benzoquinone;Tetrahydroxybenzoquinone, CAS# 319-89-1, Formula: C6H4O6, MWT: 172.0924, Solubility: DMSO: ≥ 1.6 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Naftidrofuryl (oxalate), Alternative-names: Nafronyl oxalate salt, CAS# 3200-06-4, Formula: C26H35NO7, MWT: 473.5586, Solubility: DMSO: 10 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Lipoamide, Alternative-names: (±)-α-Lipoamide;DL-Lipoamide;DL-6,8-Thioctamide, CAS# 940-69-2, Formula: C8H15NOS2, MWT: 205.3408, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Labetalol (hydrochloride), Alternative-names: AH-5158 hydrochloride;Sch-15719W, CAS# 32780-64-6, Formula: C19H25ClN2O3, MWT: 364.8664, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| N-Acetylprocainamide, Alternative-names: Acecainide;NAPA, CAS# 32795-44-1, Formula: C15H23N3O2, MWT: 277.362, Solubility: DMSO: ≥150 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: DNA Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nomifensine, Alternative-names: (¡À)-Nomifensin, CAS# 24526-64-5, Formula: C16H18N2, MWT: 238.3275, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nomifensine (maleate), Alternative-names: (±)-Nomifensine maleat, CAS# 32795-47-4, Formula: C20H22N2O4, MWT: 354.3997, Solubility: DMSO: ≥ 80 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Amitraz, Alternative-names: BTS-27419, CAS# 33089-61-1, Formula: C19H23N3, MWT: 293.406, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Adrenergic Receptor;Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fluorothyl, Alternative-names: Bis(2,2,2-trifluoroethyl) ether;Flurothyl, CAS# 333-36-8, Formula: C4H4F6O, MWT: 182.0644, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Diazinon, Alternative-names: Dimpylate, CAS# 333-41-5, Formula: C12H21N2O3PS, MWT: 304.3455, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| Flunisolide, Alternative-names: , CAS# 3385-03-3, Formula: C24H31FO6, MWT: 434.4977, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Buspirone (hydrochloride), Alternative-names: , CAS# 33386-08-2, Formula: C21H32ClN5O2, MWT: 421.9641, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Metaraminol (tartrate), Alternative-names: Metaradrine tartrate, CAS# 33402-03-8, Formula: C13H19NO8, MWT: 317.2919, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cefoxitin (sodium), Alternative-names: , CAS# 33564-30-6, Formula: C16H16N3NaO7S2, MWT: 449.4339, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| L-Cycloserine, Alternative-names: (S)-4-Amino-3-isoxazolidone;(S)-Cycloserine, CAS# 339-72-0, Formula: C3H6N2O2, MWT: 102.0919, Solubility: H<sub>2</sub>O: ≥ 36 mg/mL, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Triclosan, Alternative-names: , CAS# 3380-34-5, Formula: C12H7Cl3O2, MWT: 289.5418, Solubility: DMSO: ≥ 3.1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection;Autophagy, Target: Fungal;Bacterial;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Temephos, Alternative-names: Temefos, CAS# 3383-96-8, Formula: C16H20O6P2S3, MWT: 466.4689, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Auranofin, Alternative-names: SKF-39162, CAS# 34031-32-8, Formula: C20H36AuO9PS, MWT: 680.4998, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fipexide, Alternative-names: , CAS# 34161-24-5, Formula: C20H21ClN2O4, MWT: 388.8447, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: Dopamine Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Glucosamine, Alternative-names: D-Glucosamine;Chitosamine, CAS# 3416-24-8, Formula: C6H13NO5, MWT: 179.1711, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Orphenadrine (hydrochloride), Alternative-names: , CAS# 341-69-5, Formula: C18H24ClNO, MWT: 305.8423, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cefamandole, Alternative-names: Cephamandole, CAS# 34444-01-4, Formula: C18H18N6O5S2, MWT: 462.5027, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Givinostat, Alternative-names: Gavinostat;ITF-2357, CAS# 497833-27-9, Formula: C24H27N3O4, MWT: 421.4889, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Givinostat (hydrochloride), Alternative-names: Gavinostat hydrochloride;ITF-2357 hydrochloride, CAS# 199657-29-9, Formula: C24H28ClN3O4, MWT: 457.9498, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Tilmicosin (phosphate), Alternative-names: LY-177370 phosphate;EL-870 phosphate, CAS# 137330-13-3, Formula: C46H83N2O17P, MWT: 967.1282, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Crotamiton, Alternative-names: , CAS# 483-63-6, Formula: C13H17NO, MWT: 203.2802, Solubility: DMSO: ≥ 58 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Urethane, Alternative-names: Carbamic acid ethyl ester;Ethyl carbamate;Ethylurethane, CAS# 51-79-6, Formula: C3H7NO2, MWT: 89.09318, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Octinoxate, Alternative-names: 2-Ethylhexyl 4-methoxycinnamate;Octyl methoxycinnamate, CAS# 5466-77-3, Formula: C18H26O3, MWT: 290.3972, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Cefuroxime (sodium), Alternative-names: Cefuroxime sodium salt, CAS# 56238-63-2, Formula: C16H15N4NaO8S, MWT: 446.3671, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Trihexyphenidyl (hydrochloride), Alternative-names: , CAS# 52-49-3, Formula: C20H32ClNO, MWT: 337.9272, Solubility: DMSO: < 7.2 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Citalopram (hydrobromide), Alternative-names: (¡À)-Citalopram hydrobromide;Lu 10-171, CAS# 59729-32-7, Formula: C20H22BrFN2O, MWT: 405.3039, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;Autophagy, Target: Serotonin Transporter;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Taurocholic Acid (sodium hydrate), Alternative-names: Sodium taurocholate hydrate, CAS# 345909-26-4, Formula: C26H47NNaO8S+, MWT: 556.7075007, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| Clidinium (bromide), Alternative-names: Ro 2-3773, CAS# 3485-62-9, Formula: C22H26BrNO3, MWT: 432.3507, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sulbentine, Alternative-names: Dibenzthione, CAS# 350-12-9, Formula: C17H18N2S2, MWT: 314.4682, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Imazalil, Alternative-names: Enilconazole, CAS# 35554-44-0, Formula: C14H14Cl2N2O, MWT: 297.1797, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Benzbromarone, Alternative-names: , CAS# 3562-84-3, Formula: C17H12Br2O3, MWT: 424.0834, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Xanthine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Menbutone, Alternative-names: Genabilic acid, CAS# 3562-99-0, Formula: C15H14O4, MWT: 258.2693, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ramifenazone, Alternative-names: Isopropylaminoantipyrine, CAS# 3615-24-5, Formula: C14H19N3O, MWT: 245.3202, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Fenbufen, Alternative-names: CL-82204, CAS# 36330-85-5, Formula: C16H14O3, MWT: 254.2806, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tolperisone (hydrochloride), Alternative-names: , CAS# 3644-61-9, Formula: C16H24ClNO, MWT: 281.8209, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Diazoxide, Alternative-names: Sch-6783;SRG-95213, CAS# 364-98-7, Formula: C8H7ClN2O2S, MWT: 230.6714, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Autophagy;Membrane Transporter/Ion Channel, Target: Autophagy;Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Eprodisate (disodium), Alternative-names: NC-503, CAS# 36589-58-9, Formula: C3H6Na2O6S2, MWT: 248.1857, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Chlorhexidine (dihydrochloride), Alternative-names: , CAS# 3697-42-5, Formula: C22H32Cl4N10, MWT: 578.3685, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Denatonium (benzoate), Alternative-names: THS-839, CAS# 3734-33-6, Formula: C28H34N2O3, MWT: 446.5811, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Diloxanide furoate, Alternative-names: , CAS# 3736-81-0, Formula: C14H11Cl2NO4, MWT: 328.1474, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Furaltadone (hydrochloride), Alternative-names: , CAS# 3759-92-0, Formula: C13H17ClN4O6, MWT: 360.7503, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Bacampicillin, Alternative-names: , CAS# 50972-17-3, Formula: C21H27N3O7S, MWT: 465.52, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Bacampicillin (hydrochloride), Alternative-names: , CAS# 37661-08-8, Formula: C21H28ClN3O7S, MWT: 501.9809, Solubility: DMSO: ≥ 5.1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Clofoctol, Alternative-names: , CAS# 37693-01-9, Formula: C21H26Cl2O, MWT: 365.3365, Solubility: DMSO: ≥ 3.7 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Piperacetazine, Alternative-names: , CAS# 3819-00-9, Formula: C24H30N2O2S, MWT: 410.5722, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Glafenine, Alternative-names: Glafenin, CAS# 3820-67-5, Formula: C19H17ClN2O4, MWT: 372.8023, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Penbutolol (sulfate), Alternative-names: (-)-Terbuclomine, CAS# 38363-32-5, Formula: C18H29NO2 . 1/2 H2O4S, MWT: 340.47, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Hydrocortisone (phosphate), Alternative-names: Hydrocortisone 21-phosphate, CAS# 3863-59-0, Formula: C21H31O8P, MWT: 442.4398, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Trioxsalen, Alternative-names: Trisoralen;Trioxysalen;Trimethylpsoralen;TMP, CAS# 3902-71-4, Formula: C14H12O3, MWT: 228.2433, Solubility: DMSO: 6.6 mg/mL (Need ultrasonic and warming), Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nitroxoline, Alternative-names: 8-Hydroxy-5-nitroquinoline;5-Nitro-8-quinolinol, CAS# 4008-48-4, Formula: C9H6N2O3, MWT: 190.1555, Solubility: DMSO: ≥ 2 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy, Target: Bacterial;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Methoprene, Alternative-names: ZR-515, CAS# 40596-69-8, Formula: C19H34O3, MWT: 310.4715, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Fluroxene, Alternative-names: 2,2,2-Trifluoroethyl vinyl ether, CAS# 406-90-6, Formula: C4H5F3O, MWT: 126.0771, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Bromopride, Alternative-names: , CAS# 4093-35-0, Formula: C14H22BrN3O2, MWT: 344.2474, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cyproheptadine (hydrochloride sesquihydrate), Alternative-names: , CAS# 41354-29-4, Formula: C21H21N . 3/2H2O . HCl, MWT: 350.88, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein;Neuronal Signaling;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ciclopirox (olamine), Alternative-names: Ciclopirox ethanolamine, CAS# 41621-49-2, Formula: C14H24N2O3, MWT: 268.352, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cefamandole (nafate), Alternative-names: Cefamandole formate sodium;Cephamandole nafate, CAS# 42540-40-9, Formula: C19H17N6NaO6S2, MWT: 512.4946, Solubility: DMSO: ≥ 41 mg/mL; H<sub>2</sub>O: ≥ 29 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ajmaline, Alternative-names: Cardiorythmine;(+)-Ajmaline, CAS# 4360-12-7, Formula: C20H26N2O2, MWT: 326.43264, Solubility: DMSO: ≥ 66 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Membrane Transporter/Ion Channel, Target: Potassium Channel;Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Cyclandelate, Alternative-names: 3,5,5-Trimethylcyclohexyl mandelate, CAS# 456-59-7, Formula: C17H24O3, MWT: 276.3707, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| DL-Carnitine, Alternative-names: (±)-Carnitin, CAS# 406-76-8, Formula: C7H15NO3, MWT: 161.1989, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Bekanamycin, Alternative-names: Kanamycin B, CAS# 4696-76-8, Formula: C18H37N5O10, MWT: 483.5139, Solubility: H<sub>2</sub>O: ≥ 37 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Teicoplanin, Alternative-names: Antibiotic MDL-507;MDL-507, CAS# 61036-62-2, Formula: C130H175Cl2N9O37R6, MWT: 2526.725, Solubility: DMSO: ≥ 25.2 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Cediranib (maleate), Alternative-names: AZD-2171 maleate, CAS# 857036-77-2, Formula: C29H31FN4O7, MWT: 566.5774432, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: Phase 3, Pathway: Protein Tyrosine Kinase/RTK;Protein Tyrosine Kinase/RTK;Autophagy, Target: VEGFR;PDGFR;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| GDC-0339, Alternative-names: , CAS# 1428569-85-0, Formula: C20H22F3N7OS, MWT: 465.4952, Solubility: DMSO: ≥ 52 mg/mL, Clinical_Information: No Development Reported, Pathway: JAK/STAT Signaling, Target: Pim, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| ARV-825, Alternative-names: , CAS# 1818885-28-7, Formula: C46H47ClN8O9S, MWT: 923.4316, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics;PROTAC, Target: Epigenetic Reader Domain;PROTAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Gluconate (sodium), Alternative-names: D-Gluconic acid sodium salt;Sodium D-gluconate;D-Gluconate sodium salt, CAS# 527-07-1, Formula: C6H11NaO7, MWT: 218.1371, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Lactulose, Alternative-names: 4-O-β-D-Galactopyranosyl-D-fructose, CAS# 4618-18-2, Formula: C12H22O11, MWT: 342.2965, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| (+)-Camphor, Alternative-names: D-(+)-Camphor;(1R)-(+)-Camphor, CAS# 464-49-3, Formula: C10H16O, MWT: 152.2334, Solubility: DMSO: ≥ 1.3 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Estradiol (benzoate), Alternative-names: , CAS# 50-50-0, Formula: C25H28O3, MWT: 376.488, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Anethole (trithione), Alternative-names: , CAS# 532-11-6, Formula: C10H8OS3, MWT: 240.3649, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| i-Inositol, Alternative-names: myo-Inositol;meso-Inositol, CAS# 87-89-8, Formula: C6H12O6, MWT: 180.1559, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Phase 4, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Butylparaben, Alternative-names: Butyl parahydroxybenzoate;Butyl paraben;Butyl 4-hydroxybenzoate, CAS# 94-26-8, Formula: C11H14O3, MWT: 194.2271, Solubility: DMSO: ≥ 1.8 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Sanguinarine (chloride), Alternative-names: Pseudochelerythrine chloride;Sanguinarium chloride, CAS# 5578-73-4, Formula: C20H14ClNO4, MWT: 367.7825, Solubility: 10 mM in DMSO; H<sub>2</sub>O: < 7.8 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt;MAPK/ERK Pathway;Autophagy, Target: ERK;ERK;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ticarcillin (disodium), Alternative-names: Ticarcillin disodium salt, CAS# 4697-14-7, Formula: C15H14N2Na2O6S2, MWT: 428.391, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Equilin, Alternative-names: 7-Dehydroestrone, CAS# 474-86-2, Formula: C18H20O2, MWT: 268.3502, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Cotinine, Alternative-names: (-)-Cotinine;(S)-Cotinine;NIH-10498, CAS# 486-56-6, Formula: C10H12N2O, MWT: 176.2151, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Vinburnine, Alternative-names: (-)-Eburnamonine;(-)-Vincamone, CAS# 4880-88-0, Formula: C19H22N2O, MWT: 294.3908, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Hydrastinine (hydrochloride), Alternative-names: , CAS# 4884-68-8, Formula: C11H14ClNO3, MWT: 243.6868, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Chromocarb, Alternative-names: Chromone-2-carboxylic acid, CAS# 4940-39-0, Formula: C10H6O4, MWT: 190.1522, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Hydrocortisone (acetate), Alternative-names: Hydrocortisone 21-acetate, CAS# 50-03-3, Formula: C23H32O6, MWT: 404.4966, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Beclamide, Alternative-names: N-Benzyl-3-chloropropionamide, CAS# 501-68-8, Formula: C10H12ClNO, MWT: 197.6614, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dixanthogen, Alternative-names: , CAS# 502-55-6, Formula: C6H10O2S4, MWT: 242.4024, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Propantheline (bromide), Alternative-names: , CAS# 50-34-0, Formula: C23H30BrNO3, MWT: 448.3932, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Meglutol, Alternative-names: Dicrotalic acid;3-Hydroxy-3-methylglutaric acid, CAS# 503-49-1, Formula: C6H10O5, MWT: 162.1406, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: HMG-CoA Reductase (HMGCR), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nanofin, Alternative-names: 2,6-Lupetidine, CAS# 504-03-0, Formula: C7H15N, MWT: 113.2007, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Terfenadine, Alternative-names: (±)-Terfenadine;MDL-991, CAS# 50679-08-8, Formula: C32H41NO2, MWT: 471.6734, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tetramisole (hydrochloride), Alternative-names: (¡À)-Tetramisole hydrochloride;DL-Tetramisole hydrochloride;R-829, CAS# 5086-74-8, Formula: C11H13ClN2S, MWT: 240.7523, Solubility: DMSO: ≥ 2.6 mg/mL; DMSO: < 9.4 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Metabolic Enzyme/Protease, Target: Parasite ;Phosphatase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2g |
| Tiapride (hydrochloride), Alternative-names: , CAS# 51012-33-0, Formula: C15H25ClN2O4S, MWT: 364.888, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Amcinonide, Alternative-names: CL-34699, CAS# 51022-69-6, Formula: C28H35FO7, MWT: 502.5717, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Terutroban, Alternative-names: S-18886, CAS# 165538-40-9, Formula: C20H22ClNO4S, MWT: 407.911, Solubility: DMSO: ≥ 22 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| ELN-441958, Alternative-names: , CAS# 913064-47-8, Formula: C29H29ClN4O2, MWT: 501.0192, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Bradykinin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| MK-5046, Alternative-names: , CAS# 1022152-70-0, Formula: C20H18F6N4O, MWT: 444.3735392, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Bombesin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 10-Undecenoic acid (zinc salt), Alternative-names: Zinc undecylenate, CAS# 557-08-4, Formula: C22H38O4Zn, MWT: 431.9147, Solubility: DMSO: ≥ 4.3 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dehydroacetic acid, Alternative-names: Biocide 470F, CAS# 520-45-6, Formula: C8H8O4, MWT: 168.1467, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection;Anti-infection, Target: Fungal;Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Flufenamic acid, Alternative-names: , CAS# 530-78-9, Formula: C14H10F3NO2, MWT: 281.2299, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 6-Acetamidohexanoic acid, Alternative-names: Acexamic Acid;6-Acetamidocaproic acid, CAS# 57-08-9, Formula: C8H15NO3, MWT: 173.2096, Solubility: DMSO: ≥ 1.8 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Docusate (Sodium), Alternative-names: Dioctyl sulfosuccinate sodium salt, CAS# 577-11-7, Formula: C20H37NaO7S, MWT: 444.5583, Solubility: H<sub>2</sub>O: ≥ 20 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cetylpyridinium (chloride monohydrate), Alternative-names: Hexadecylpyridinium chloride monohydrate, CAS# 6004-24-6, Formula: C21H40ClNO, MWT: 358.0014, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Citric acid (trilithium salt tetrahydrate), Alternative-names: Lithium citrate tribasic tetrahydrate;Trilithium citrate tetrahydrate, CAS# 6080-58-6, Formula: C6H13Li3O11, MWT: 281.98, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 4-Aminohippuric acid, Alternative-names: p-Aminohippuric acid, CAS# 61-78-9, Formula: C9H10N2O3, MWT: 194.1873, Solubility: H<sub>2</sub>O: ≥ 1.7 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| L-Ornithine, Alternative-names: (S)-2,5-Diaminopentanoic acid, CAS# 70-26-8, Formula: C5H12N2O2, MWT: 132.161, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Estropipate, Alternative-names: Piperazine estrone sulfate;Estrone sulfate piperazine salt, CAS# 7280-37-7, Formula: C22H32N2O5S, MWT: 436.5649, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Cefixime, Alternative-names: FR-17027;FK-027;CL-284635, CAS# 79350-37-1, Formula: C16H15N5O7S2, MWT: 453.4496, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Sulfamethoxypyridazine, Alternative-names: , CAS# 80-35-3, Formula: C11H12N4O3S, MWT: 280.303, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Butamben, Alternative-names: Butyl 4-aminobenzoate, CAS# 94-25-7, Formula: C11H15NO2, MWT: 193.2423, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| 7-Aminocephalosporanic acid, Alternative-names: 7-ACA, CAS# 957-68-6, Formula: C10H12N2O5S, MWT: 272.2777, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Xylose, Alternative-names: D-(+)-Xylose;(+)-Xylose;Wood sugar, CAS# 58-86-6, Formula: C5H10O5, MWT: 150.1299, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Coptisine (chloride), Alternative-names: , CAS# 6020-18-4, Formula: C19H14ClNO4, MWT: 355.7718, Solubility: DMSO: 10.75 mg/mL, Clinical_Information: No Development Reported, Pathway: TGF-beta/Smad;Stem Cell/Wnt;Cell Cycle/DNA Damage, Target: ROCK;ROCK;ROCK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Piperonyl butoxide, Alternative-names: ENT-14250, CAS# 51-03-6, Formula: C19H30O5, MWT: 338.4385, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nialamide, Alternative-names: , CAS# 51-12-7, Formula: C16H18N4O2, MWT: 298.3397, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pralidoxime (chloride), Alternative-names: 2-PAM chloride, CAS# 51-15-0, Formula: C7H9ClN2O, MWT: 172.6122, Solubility: DMSO: < 7 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tiratricol, Alternative-names: 3,3',5-Triiodothyroacetic acid, CAS# 51-24-1, Formula: C14H9I3O4, MWT: 621.9323, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Alrestatin, Alternative-names: AY-22284, CAS# 51411-04-2, Formula: C14H9NO4, MWT: 255.2256, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Aldose Reductase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Alrestatin (sodium), Alternative-names: AY-22284A, CAS# 51876-97-2, Formula: C14H8NNaO4, MWT: 277.2074, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Aldose Reductase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Fludrocortisone, Alternative-names: 9α-Fludrocortisone;9α-Fluorcortisol, CAS# 127-31-1, Formula: C21H29FO5, MWT: 380.4504, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Mineralocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Fludrocortisone (acetate), Alternative-names: 9α-Fludrocortisone acetate;9α-Fluorcortisol acetate, CAS# 514-36-3, Formula: C23H31FO6, MWT: 422.487, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: Launched, Pathway: Autophagy;Metabolic Enzyme/Protease, Target: Autophagy;Mineralocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Atropine, Alternative-names: Tropine tropate;DL-Hyoscyamine, CAS# 51-55-8, Formula: C17H23NO3, MWT: 289.3694, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Atropine (sulfate), Alternative-names: Sulfatropinol, CAS# 55-48-1, Formula: C17H23NO3 . 1/2 H2O4S , MWT: 338.41, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Carbamoylcholine (chloride), Alternative-names: Carbachol;Carbamylcholine chloride, CAS# 51-83-2, Formula: C6H15ClN2O2, MWT: 182.6485, Solubility: DMSO: 6.4 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein;Neuronal Signaling;Membrane Transporter/Ion Channel, Target: mAChR;mAChR;nAChR;nAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Etofylline, Alternative-names: 7-(β-Hydroxyethyl)theophylline;7-Theophyllineethanol, CAS# 519-37-9, Formula: C9H12N4O3, MWT: 224.2166, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pipemidic acid, Alternative-names: , CAS# 51940-44-4, Formula: C14H17N5O3, MWT: 303.3165, Solubility: DMSO: < 7 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Broxyquinoline, Alternative-names: Dibromohydroxyquinoline;5,7-Dibromo-8-hydroxyquinoline, CAS# 521-74-4, Formula: C9H5Br2NO, MWT: 302.9501, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Trimipramine (maleate), Alternative-names: , CAS# 521-78-8, Formula: C24H30N2O4, MWT: 410.506, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;GPCR/G Protein, Target: Adrenergic Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dimenhydrinate, Alternative-names: , CAS# 523-87-5, Formula: C24H28ClN5O3, MWT: 469.9638, Solubility: DMSO: ≥ 37 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Oxeladin (citrate), Alternative-names: , CAS# 52432-72-1, Formula: C26H41NO10, MWT: 527.6044, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sulfaphenazole, Alternative-names: , CAS# 526-08-9, Formula: C15H14N4O2S, MWT: 314.3623, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Metrifonate, Alternative-names: Trichlorfon, CAS# 52-68-6, Formula: C4H8Cl3O4P, MWT: 257.4367, Solubility: H<sub>2</sub>O: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cefotiam (hydrochloride), Alternative-names: Cefotiam dihydrochloride, CAS# 66309-69-1, Formula: C18H25Cl2N9O4S3, MWT: 598.55, Solubility: DMSO: ≥ 6.1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
Sisomicin (sulfate), Alternative-names: , CAS# 53179-09-2, Formula: C19H37N5O7 . 5/2 H2SO4, MWT: 692.72, Solubility: H<sub>2</sub>O: 20 mg/mL
, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| Ribostamycin (sulfate), Alternative-names: Vistamycin sulfate, CAS# 53797-35-6, Formula: C17H36N4O14S, MWT: 552.5511, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Protoporphyrin IX, Alternative-names: , CAS# 553-12-8, Formula: C34H34N4O4, MWT: 562.6581, Solubility: DMSO: ≥ 5.6 mg/mL; DMSO: 6.4 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cephalothin (sodium), Alternative-names: Cefalotin sodium, CAS# 58-71-9, Formula: C16H15N2NaO6S2, MWT: 418.4199, Solubility: H<sub>2</sub>O: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Mebhydrolin (napadisylate), Alternative-names: Mebhydroline 1,5-naphthalenedisulfonate salt, CAS# 6153-33-9, Formula: C48H48N4O6S2, MWT: 841.0479, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| (-)-Sparteine (sulfate pentahydrate), Alternative-names: (-)-Sparteine sulfate salt;Lupinidine sulfate pentahydrate, CAS# 6160-12-9, Formula: C15H26N2 . H2SO4 .5H2O, MWT: 422.54, Solubility: DMSO: ≥ 3.3 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Chlortetracycline (hydrochloride), Alternative-names: 7-Chlorotetracycline hydrochloride, CAS# 64-72-2, Formula: C22H24Cl2N2O8, MWT: 515.3406, Solubility: H<sub>2</sub>O: 6.66 mg/mL; DMSO: < 0.1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| Apramycin (sulfate), Alternative-names: Nebramycin II, CAS# 65710-07-8, Formula: C21H43N5O15S, MWT: 637.6556, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Choline (chloride), Alternative-names: , CAS# 67-48-1, Formula: C5H14ClNO, MWT: 139.6238, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Lincomycin (hydrochloride hydrate), Alternative-names: Lincomycin hydrochloride monohydrate, CAS# 7179-49-9, Formula: C18H37ClN2O7S, MWT: 461.0136, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| Florfenicol, Alternative-names: (-)-Florfenicol;SCH-25298, CAS# 73231-34-2, Formula: C12H14Cl2FNO4S, MWT: 358.2133, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pempidine, Alternative-names: 1,2,2,6,6-Pentamethylpiperidine, CAS# 79-55-0, Formula: C10H21N, MWT: 155.2804, Solubility: DMSO: ≥ 2.1 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Lactitol (monohydrate), Alternative-names: D-Lactitol monohydrate, CAS# 81025-04-9, Formula: C12H26O12, MWT: 362.3276, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nefazodone (hydrochloride), Alternative-names: BMY-13754;MJ-13754-1, CAS# 82752-99-6, Formula: C25H33Cl2N5O2, MWT: 506.4678, Solubility: DMSO: 17.5 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;GPCR/G Protein, Target: Adrenergic Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Acetrizoic acid, Alternative-names: , CAS# 85-36-9, Formula: C9H6I3NO3, MWT: 556.8622, Solubility: DMSO: ≥ 5.6 mg/mL; H<sub>2</sub>O: < 5.6 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Phthalylsulfathiazole, Alternative-names: N4-Phthalylsulfathiazole, CAS# 85-73-4, Formula: C17H13N3O5S2, MWT: 403.4322, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Salicyl alcohol, Alternative-names: 2-Hydroxybenzyl alcohol;Saligenin, CAS# 90-01-7, Formula: C7H8O2, MWT: 124.1372, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cyromazine, Alternative-names: Cyromazin;CGA-72662, CAS# 66215-27-8, Formula: C6H10N6, MWT: 166.1838, Solubility: DMSO: ≥ 1.8 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| TEPP-46, Alternative-names: ML-265, CAS# 1221186-53-3, Formula: C17H16N4O2S2, MWT: 372.4645, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Pyruvate Dehydrogenase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PFI-4, Alternative-names: , CAS# 900305-37-5, Formula: C21H24N4O3, MWT: 380.4402, Solubility: DMSO: 26 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Epigenetic Reader Domain, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| GSK-5959, Alternative-names: , CAS# 901245-65-6, Formula: C22H26N4O3, MWT: 394.4668, Solubility: DMSO: < 7.8 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Epigenetic Reader Domain, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Bremelanotide (Acetate), Alternative-names: PT-141 Acetate, CAS# 1607799-13-2, Formula: C52H72N14O12, MWT: 1085.215, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pardoprunox (hydrochloride), Alternative-names: SLV-308 hydrochloride;DU-126891 hydrochloride, CAS# 269718-83-4, Formula: C12H16ClN3O2, MWT: 269.7273, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: GPCR/G Protein;Neuronal Signaling;GPCR/G Protein;Neuronal Signaling;GPCR/G Protein, Target: Dopamine Receptor;Dopamine Receptor;Adrenergic Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Hetacillin, Alternative-names: , CAS# 3511-16-8, Formula: C19H23N3O4S, MWT: 389.4686, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Hetacillin (potassium), Alternative-names: Potassium hetacillin, CAS# 5321-32-4, Formula: C19H22KN3O4S, MWT: 427.559, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Exalamide, Alternative-names: 2-(Hexyloxy)benzamide, CAS# 53370-90-4, Formula: C13H19NO2, MWT: 221.2955, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Promazine (hydrochloride), Alternative-names: , CAS# 53-60-1, Formula: C17H21ClN2S, MWT: 320.88, Solubility: H<sub>2</sub>O:≥ 48 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Diperodon (hydrochloride), Alternative-names: , CAS# 537-12-2, Formula: C22H28ClN3O4, MWT: 433.9284, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
Carprofen, Alternative-names: , CAS# 53716-49-7, Formula: C15H12ClNO2, MWT: 273.7143, Solubility: DMSO: ≥ 33 mg/mL
, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Isovaleramide, Alternative-names: 3-Methylbutanamide, CAS# 541-46-8, Formula: C5H11NO, MWT: 101.1469, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Camylofine, Alternative-names: , CAS# 54-30-8, Formula: C19H32N2O2, MWT: 320.4696, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Heptaminol (hydrochloride), Alternative-names: RP-2831 hydrochloride, CAS# 543-15-7, Formula: C8H20ClNO, MWT: 181.7035, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Metyrapone, Alternative-names: Su-4885, CAS# 54-36-4, Formula: C14H14N2O, MWT: 226.2738, Solubility: H<sub>2</sub>O: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: Autophagy;Metabolic Enzyme/Protease, Target: Autophagy;Cytochrome P450, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| 2-Amino-6-methylheptane, Alternative-names: 1,5-Dimethylhexylamine;6-Methyl-2-heptylamine, CAS# 543-82-8, Formula: C8H19N, MWT: 129.2432, Solubility: DMSO: < 1 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Acetohydroxamic acid, Alternative-names: AHA, CAS# 546-88-3, Formula: C2H5NO2, MWT: 75.0666, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Sulfacarbamide, Alternative-names: , CAS# 547-44-4, Formula: C7H9N3O3S, MWT: 215.2297, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Suloctidil, Alternative-names: , CAS# 54767-75-8, Formula: C20H35NOS, MWT: 337.563, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Na+/K+ ATPase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pronethalol, Alternative-names: (¡À)-Pronethalo, CAS# 54-80-8, Formula: C15H19NO, MWT: 229.3175, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Drofenine (hydrochloride), Alternative-names: Hexahydroadiphenine hydrochloride, CAS# 548-66-3, Formula: C20H32ClNO2, MWT: 353.9266, Solubility: DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Droperidol, Alternative-names: Dehydrobenzperidol, CAS# 548-73-2, Formula: C22H22FN3O2, MWT: 379.4274, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| BAY 1161909, Alternative-names: Empesertib, CAS# 1443763-60-7, Formula: C29H26FN5O4S, MWT: 559.6113, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage;Cytoskeleton, Target: Mps1;Mps1, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Clopidogrel thiolactone, Alternative-names: , CAS# 1147350-75-1, Formula: C16H16ClNO3S, MWT: 337.82114, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: P2Y Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| W-54011, Alternative-names: , CAS# 405098-33-1, Formula: C30H37ClN2O2, MWT: 493.08, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| Pentylenetetrazol, Alternative-names: Pentylenetetrazole, CAS# 54-95-5, Formula: C6H10N4, MWT: 138.1704, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Salsalate, Alternative-names: Salicylsalicylic acid;Disalicylic acid, CAS# 552-94-3, Formula: C14H10O5, MWT: 258.2262, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 4-(Aminomethyl)benzoic acid, Alternative-names: α-Amino-p-toluic acid;Aminomethylbenzoic acid, CAS# 56-91-7, Formula: C8H9NO2, MWT: 151.1626, Solubility: H<sub>2</sub>O: ≥ 20 mg/mL; DMSO: < 1.5 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Cetrimonium (bromide), Alternative-names: Cetyltrimethylammonium Bromide;Hexadecyltrimethylammonium bromide;CTAB, CAS# 57-09-0, Formula: C19H42BrN, MWT: 364.4475, Solubility: H<sub>2</sub>O: ≥ 66.66 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Piperacillin (sodium), Alternative-names: Sodium piperacillin, CAS# 59703-84-3, Formula: C23H26N5NaO7S, MWT: 539.5366, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Amodiaquin (dihydrochloride dihydrate), Alternative-names: Amodiaquine dihydrochloride dihydrate, CAS# 6398-98-7, Formula: C20H22ClN3O . 2H2O . 2HCl, MWT: 464.81, Solubility: H<sub>2</sub>O: ≥ 4.7 mg/mL, Clinical_Information: Launched, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Bemegride, Alternative-names: 3-Ethyl-3-methylglutarimide;Bemegrid, CAS# 64-65-3, Formula: C8H13NO2, MWT: 155.1943, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Furazolidone, Alternative-names: , CAS# 67-45-8, Formula: C8H7N3O5, MWT: 225.1583, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| DL-Glutamine, Alternative-names: (¡À)-Glutamine;DL-Gl, CAS# 6899-04-3, Formula: C5H10N2O3, MWT: 146.1445, Solubility: DMSO: < 1.7 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Chlorquinaldol, Alternative-names: 5,7-Dichloro-8-hydroxy-2-methylquinoline, CAS# 72-80-0, Formula: C10H7Cl2NO, MWT: 228.0747, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: Fungal;Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| 4-Chloro-DL-phenylalanine, Alternative-names: PCPA;CP-10188, CAS# 7424-00-2, Formula: C9H10ClNO2, MWT: 199.6342, Solubility: H<sub>2</sub>O: < 2.1 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Tryptophan Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| 2,2,2-Tribromoethanol, Alternative-names: Tribromoethyl alcohol, CAS# 75-80-9, Formula: C2H3Br3O, MWT: 282.7566, Solubility: DMSO: ≥ 2.6 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Dehydrocholic acid, Alternative-names: , CAS# 81-23-2, Formula: C24H34O5, MWT: 402.5238, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| 4-Aminoantipyrine, Alternative-names: Ampyrone, CAS# 83-07-8, Formula: C11H13N3O, MWT: 203.2404, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Dihydrostreptomycin (sulfate), Alternative-names: Dihydrostreptomycin sesquisulfate, CAS# 5490-27-7, Formula: C21H41N7O12 . 3/2 H2SO4, MWT: 730.71, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Phase 1, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Testosterone (propionate), Alternative-names: , CAS# 57-85-2, Formula: C22H32O3, MWT: 344.4877, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Androgen Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Adrenalone (hydrochloride), Alternative-names: , CAS# 62-13-5, Formula: C9H12ClNO3, MWT: 217.6495, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Proadifen (hydrochloride), Alternative-names: SKF-525A;U-5446;RP-5171, CAS# 62-68-0, Formula: C23H32ClNO2, MWT: 389.9587, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Cytochrome P450, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Esmolol (hydrochloride), Alternative-names: , CAS# 81161-17-3, Formula: C16H26ClNO4, MWT: 331.8349, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Autophagy, Target: Adrenergic Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| 3-Methylsalicylic acid, Alternative-names: o-Cresotic acid;Hydroxytoluic acid, CAS# 83-40-9, Formula: C8H8O3, MWT: 152.1473, Solubility: DMSO: ≥ 1.5 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Diiodohydroxyquinoline, Alternative-names: Iodoquinol;5,7-Diiodo-8-hydroxyquinoline;5,7-Diiodo-8-quinolinol, CAS# 83-73-8, Formula: C9H5I2NO, MWT: 396.951, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Dienestrol, Alternative-names: , CAS# 84-17-3, Formula: C18H18O2, MWT: 266.3343, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Chloroxylenol, Alternative-names: 4-Chloro-3,5-dimethylphenol;PCMX, CAS# 88-04-0, Formula: C8H9ClO, MWT: 156.6095, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Nortriptyline (hydrochloride), Alternative-names: Desmethylamitriptyline hydrochloride, CAS# 894-71-3, Formula: C19H22ClN, MWT: 299.8377, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tazobactam, Alternative-names: CL-298741;YTR-830H, CAS# 89786-04-9, Formula: C10H12N4O5S, MWT: 300.2911, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 9-Aminoacridine, Alternative-names: Aminacrine, CAS# 90-45-9, Formula: C13H10N2, MWT: 194.2319, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 2-Ethoxybenzamide, Alternative-names: Ethenzamide, CAS# 938-73-8, Formula: C9H11NO2, MWT: 165.1891, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Chlorpropamide, Alternative-names: , CAS# 94-20-2, Formula: C10H13ClN2O3S, MWT: 276.7398, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Na+/K+ ATPase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nifuroxazide, Alternative-names: , CAS# 965-52-6, Formula: C12H9N3O5, MWT: 275.2169, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: JAK/STAT Signaling;Stem Cell/Wnt, Target: STAT;STAT, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Glucosamine (hydrochloride), Alternative-names: D-(+)-Glucosamine hydrochloride;Chitosamine hydrochloride, CAS# 66-84-2, Formula: C6H14ClNO5, MWT: 215.6321, Solubility: H<sub>2</sub>O: ≥ 34 mg/mL; DMSO: 6.2 mg/mL (Need ultrasonic), Clinical_Information: Launched, Pathway: Autophagy;Metabolic Enzyme/Protease, Target: Autophagy;HIF/HIF Prolyl-Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| RQ-00203078, Alternative-names: , CAS# 1254205-52-1, Formula: C21H13ClF6N2O5S, MWT: 554.8467, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: TRP Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Centrinone, Alternative-names: , CAS# 1798871-30-3, Formula: C26H25F2N7O6S2, MWT: 633.6468064, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: Polo-like Kinase (PLK), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| IMD-0354, Alternative-names: , CAS# 978-62-1, Formula: C15H8ClF6NO2, MWT: 383.6729, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: NF-κB, Target: IKK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| N6-[2-(4-Aminophenyl)ethyl]adenosine, Alternative-names: APNEA, CAS# 89705-21-5, Formula: C18H22N6O4, MWT: 386.4051, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: GPCR/G Protein, Target: Adenosine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| QNZ46, Alternative-names: , CAS# 1237744-13-6, Formula: C24H17N3O6, MWT: 443.4083, Solubility: DMSO: ≥ 4.4 mg/mL; DMSO: < 8 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| SYM2206, Alternative-names: , CAS# 173952-44-8, Formula: C20H22N4O3, MWT: 366.4137, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| D77, Alternative-names: , CAS# 497836-10-9, Formula: C28H22BrNO7S, MWT: 596.4458, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| LTV-1, Alternative-names: , CAS# 347379-29-7, Formula: C26H20N2O5S, MWT: 472.5124, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Phosphatase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Integrin Antagonists 27, Alternative-names: , CAS# 593274-97-6, Formula: C24H20N4O5, MWT: 444.4394, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cytoskeleton, Target: Integrin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| ML346, Alternative-names: , CAS# 100872-83-1, Formula: C14H12N2O4, MWT: 272.2561, Solubility: DMSO: ≥ 29 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease;Cell Cycle/DNA Damage, Target: HSP;HSP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| HQ-415, Alternative-names: , CAS# 430462-93-4, Formula: C25H25N3O3, MWT: 415.4843, Solubility: DMSO: 5.6 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| BoNT-IN-1, Alternative-names: , CAS# 694443-03-3, Formula: C23H20N4O3, MWT: 400.4299, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SMER18, Alternative-names: , CAS# 944153-47-3, Formula: C16H14ClNO2, MWT: 287.7409, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PROTO-1, Alternative-names: , CAS# 312951-85-2, Formula: C17H19ClN4O2S, MWT: 378.8764, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| K-Ras-IN-1, Alternative-names: , CAS# 84783-01-7, Formula: C11H13NOS, MWT: 207.292, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Ras, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| IQ-R, Alternative-names: , CAS# 1345445-57-9, Formula: C34H28N2O7, MWT: 576.5953, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| OSU-T315, Alternative-names: , CAS# 1333146-24-9, Formula: C30H30F3N5O, MWT: 533.5873, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cytoskeleton, Target: Integrin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| MSI-1436, Alternative-names: Trodusquemine;Aminosterol-1436, CAS# 186139-09-3, Formula: C37H72N4O5S, MWT: 685.05638, Solubility: 10 mM in DMSO, Clinical_Information: Phase 1, Pathway: Metabolic Enzyme/Protease, Target: Phosphatase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| ERK5-IN-1, Alternative-names: , CAS# 1234479-76-5, Formula: C25H29N7O2, MWT: 459.5435, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt;MAPK/ERK Pathway, Target: ERK;ERK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| ITD-1, Alternative-names: , CAS# 1099644-42-4, Formula: C27H29NO3, MWT: 415.524, Solubility: DMSO: < 9 mg/mL, Clinical_Information: No Development Reported, Pathway: TGF-beta/Smad, Target: TGF-β Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Setipiprant, Alternative-names: ACT-129968;KYTH-105, CAS# 866460-33-5, Formula: C24H19FN2O3, MWT: 402.4177, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Phase 3, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Indoximod, Alternative-names: NLG-8189;1-Methyl-D-tryptophan, CAS# 110117-83-4, Formula: C12H14N2O2, MWT: 218.2518, Solubility: DMSO: 0.55 mg/mL (Need ultrasonic and warming); H<sub>2</sub>O: 6.2 mg/mL (Need ultrasonic, warming and concentrated HCl), Clinical_Information: Phase 3, Pathway: Metabolic Enzyme/Protease, Target: Indoleamine 2,3-Dioxygenase (IDO), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| 3-Cyano-7-ethoxycoumarin, Alternative-names: , CAS# 117620-77-6, Formula: C12H9NO3, MWT: 215.2048, Solubility: DMSO: 16.5 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| L-655708, Alternative-names: , CAS# 130477-52-0, Formula: C18H19N3O4, MWT: 341.3611, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| NM107, Alternative-names: 2'-C-Methylcytidine;NM-107, CAS# 20724-73-6, Formula: C10H15N3O5, MWT: 257.2432, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: HCV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Amentoflavone, Alternative-names: Didemethyl-ginkgetin, CAS# 1617-53-4, Formula: C30H18O10, MWT: 538.4579, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Bergenin, Alternative-names: Cuscutin, CAS# 477-90-7, Formula: C14H16O9, MWT: 328.2715, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2mg |
| Leuprorelin, Alternative-names: Leuprolide, CAS# 53714-56-0, Formula: C59H84N16O12, MWT: 1209.39826, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: GNRH Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| Oroxylin A, Alternative-names: Baicalein 6-methyl ether;6-Methoxybaicalein, CAS# 480-11-5, Formula: C16H12O5, MWT: 284.2635, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy;Metabolic Enzyme/Protease, Target: Autophagy;HIF/HIF Prolyl-Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Efaproxiral (sodium), Alternative-names: RSR13 sodium, CAS# 170787-99-2, Formula: C20H22NNaO4, MWT: 363.3828, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Efaproxiral, Alternative-names: RSR13, CAS# 131179-95-8, Formula: C20H23NO4, MWT: 341.4009, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| ZM39923 (hydrochloride), Alternative-names: , CAS# 1021868-92-7, Formula: C23H26ClNO, MWT: 367.9117, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Stem Cell/Wnt;JAK/STAT Signaling, Target: JAK;JAK;JAK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| ZM39923, Alternative-names: , CAS# 273727-89-2, Formula: C23H25NO, MWT: 331.4507, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics;Stem Cell/Wnt;JAK/STAT Signaling, Target: JAK;JAK;JAK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| PU-WS13, Alternative-names: , CAS# 1454619-14-7, Formula: C17H20Cl2N6S, MWT: 411.3519, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease;Cell Cycle/DNA Damage, Target: HSP;HSP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Azoramide, Alternative-names: , CAS# 932986-18-0, Formula: C15H17ClN2OS, MWT: 308.8263, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Propoxycaine (hydrochloride), Alternative-names: , CAS# 550-83-4, Formula: C16H27ClN2O3, MWT: 330.8502, Solubility: DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Dimetridazole, Alternative-names: 1,2-Dimethyl-5-nitroimidazole, CAS# 551-92-8, Formula: C5H7N3O2, MWT: 141.128, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
Thonzonium (bromide), Alternative-names: , CAS# 553-08-2, Formula: C32H55BrN4O, MWT: 591.7093, Solubility: DMSO: ≥ 30 mg/mL
, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Chlorhexidine, Alternative-names: , CAS# 55-56-1, Formula: C22H30Cl2N10, MWT: 505.4466, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Trichlormethine, Alternative-names: Tris(2-chloroethyl)amine;Nitrogen mustard, CAS# 555-77-1, Formula: C6H12Cl3N, MWT: 204.5252, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cardiogenol C (hydrochloride), Alternative-names: , CAS# 1049741-55-0, Formula: C13H17ClN4O2, MWT: 296.7527, Solubility: DMSO: ≥ 59 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt;Stem Cell/Wnt, Target: β-catenin;Wnt, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| MG-101, Alternative-names: Calpain inhibitor I;ALL, CAS# 110044-82-1, Formula: C20H37N3O4, MWT: 383.5255, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Metabolic Enzyme/Protease, Target: Proteasome, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| EPZ011989 (trifluoroacetate), Alternative-names: EPZ-011989 trifluoroacetate, CAS# 1598383-41-5, Formula: C37H52F3N5O6, MWT: 719.8339, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Epigenetics, Target: Histone Methyltransferase;Epigenetic Reader Domain, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Vercirnon, Alternative-names: GSK-1605786;CCX282-B, CAS# 698394-73-9, Formula: C22H21ClN2O4S, MWT: 444.9312, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: CCR;CCR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| JNJ-7777120, Alternative-names: , CAS# 459168-41-3, Formula: C14H16ClN3O, MWT: 277.7493, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| GR79236, Alternative-names: , CAS# 124555-18-6, Formula: C15H21N5O5, MWT: 351.3577, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adenosine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cefmetazole (sodium), Alternative-names: Sodium cefmetazole, CAS# 56796-39-5, Formula: C15H16N7NaO5S3, MWT: 493.5162, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| IC261, Alternative-names: , CAS# 186611-52-9, Formula: C18H17NO4, MWT: 311.3319, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt;Cell Cycle/DNA Damage, Target: Casein Kinase;Casein Kinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| L-701324, Alternative-names: , CAS# 142326-59-8, Formula: C21H14ClNO3, MWT: 363.7938, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| CIQ, Alternative-names: , CAS# 486427-17-2, Formula: C26H26ClNO5, MWT: 467.9413, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| D-Luciferin, Alternative-names: D-(-)-Luciferin;Firefly luciferin, CAS# 2591-17-5, Formula: C11H8N2O3S2, MWT: 280.3228, Solubility: DMSO: 14.7 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Santacruzamate A, Alternative-names: CAY-10683, CAS# 1477949-42-0, Formula: C15H22N2O3, MWT: 278.3468, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Milnacipran ((1S-cis) hydrochloride), Alternative-names: Levomilnacipran hydrochloride;F-2695 hydrochloride, CAS# 175131-60-9, Formula: C15H23ClN2O, MWT: 282.8089, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Serotonin Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| BRD73954, Alternative-names: , CAS# 1440209-96-0, Formula: C16H16N2O3, MWT: 284.3098, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 25mg |
| AS601245, Alternative-names: , CAS# 345987-15-7, Formula: C20H16N6S, MWT: 372.4462, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway, Target: JNK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| AZD8186, Alternative-names: , CAS# 1627494-13-6, Formula: C24H25F2N3O4, MWT: 457.4698, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Phase 1, Pathway: PI3K/Akt/mTOR, Target: PI3K, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Kevetrin (hydrochloride), Alternative-names: 4-Isothioureidobutyronitrile hydrochloride;thioureidobutyronitrile hydrochloride;thioureido butyronitrile hydrochloride, CAS# 66592-89-0, Formula: C5H10ClN3S, MWT: 179.671, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: Phase 2, Pathway: Apoptosis, Target: MDM-2/p53, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| NU2058, Alternative-names: NU-2058;O6-(Cyclohexylmethyl)guanine, CAS# 161058-83-9, Formula: C12H17N5O, MWT: 247.2963, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: CDK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Berbamine (dihydrochloride), Alternative-names: , CAS# 6078-17-7, Formula: C37H42Cl2N2O6, MWT: 681.6452, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy;NF-κB, Target: Autophagy;NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Cantharidin, Alternative-names: , CAS# 56-25-7, Formula: C10H12O4, MWT: 196.1999, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 25mg |
| Nylidrin (hydrochloride), Alternative-names: Buphenine hydrochloride, CAS# 849-55-8, Formula: C19H26ClNO2, MWT: 335.8682, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Anisomycin, Alternative-names: Flagecidin;Wuningmeisu C, CAS# 22862-76-6, Formula: C14H19NO4, MWT: 265.305, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway;Anti-infection, Target: JNK;Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| JH-II-127, Alternative-names: , CAS# 1700693-08-8, Formula: C19H21ClN6O3, MWT: 416.8615, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: LRRK2, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| (-)-Blebbistatin, Alternative-names: (S)-(-)-Blebbistatin, CAS# 856925-71-8, Formula: C18H16N2O2, MWT: 292.3318, Solubility: DMSO: 5.2 mg/mL (Need ultrasonic and warming), Clinical_Information: No Development Reported, Pathway: Cytoskeleton, Target: Myosin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| AZD-8835, Alternative-names: , CAS# 1620576-64-8, Formula: C22H31N9O3, MWT: 469.54, Solubility: DMSO: 16 mg/mL, Clinical_Information: No Development Reported, Pathway: PI3K/Akt/mTOR, Target: PI3K, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
Cycloheximide, Alternative-names: Naramycin A;Actidione, CAS# 66-81-9, Formula: C15H23NO4, MWT: 281.3474, Solubility: DMSO: ≥ 33 mg/mL; H<sub>2</sub>O: 20 mg/mL (Need ultrasonic and warming)
, Clinical_Information: No Development Reported, Pathway: Anti-infection;Cell Cycle/DNA Damage;Autophagy, Target: Fungal;DNA/RNA Synthesis;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| D-Luciferin (sodium salt), Alternative-names: D-(-)-Luciferin sodium salt;Firefly luciferin sodium salt, CAS# 103404-75-7, Formula: C11H7N2NaO3S2, MWT: 302.3047, Solubility: H<sub>2</sub>O, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Erdafitinib, Alternative-names: JNJ-42756493, CAS# 1346242-81-6, Formula: C25H30N6O2, MWT: 446.5447, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: Phase 2, Pathway: Protein Tyrosine Kinase/RTK, Target: FGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Garenoxacin, Alternative-names: , CAS# 194804-75-6, Formula: C23H20F2N2O4, MWT: 426.4127, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Garenoxacin (Mesylate hydrate), Alternative-names: , CAS# 223652-90-2, Formula: C24H26F2N2O8S, MWT: 540.5336, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CPDA, Alternative-names: , CAS# 1415834-63-7, Formula: C20H15ClF2N2O2, MWT: 388.7951, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| KML29, Alternative-names: , CAS# 1380424-42-9, Formula: C24H21F6NO7, MWT: 549.4164, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: MAGL, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| VR23, Alternative-names: , CAS# 1624602-30-7, Formula: C19H16ClN5O6S, MWT: 477.8782, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Proteasome, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Bethanechol, Alternative-names: Carbamyl-β-methylcholine, CAS# 674-38-4, Formula: C7H17N2O2+, MWT: 161.2215, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Alda-1, Alternative-names: , CAS# 349438-38-6, Formula: C15H11Cl2NO3, MWT: 324.1588, Solubility: DMSO: ≥ 51 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Aldehyde Dehydrogenase (ALDH), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| β-Nicotinamide mononucleotide, Alternative-names: β-NM, CAS# 1094-61-7, Formula: C11H15N2O8P, MWT: 334.2192, Solubility: H<sub>2</sub>O: ≥ 28 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| NADPH (tetracyclohexanamine), Alternative-names: , CAS# 100929-71-3, Formula: C45H82N11O17P3, MWT: 1142.117, Solubility: DMSO: ≥ 84 mg/mL; H<sub>2</sub>O: ≥ 27 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| NADPH (tetrasodium salt), Alternative-names: , CAS# 2646-71-1, Formula: C21H26N7Na4O17P3, MWT: 833.3482, Solubility: H<sub>2</sub>O: ≥ 35 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| NADP (disodium salt), Alternative-names: Disodium NADP, CAS# 24292-60-2, Formula: C21H27N7Na2O17P3+, MWT: 788.376, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| NADP (sodium salt), Alternative-names: Sodium NADP, CAS# 1184-16-3, Formula: C21H27N7NaO17P3, MWT: 765.3868, Solubility: H<sub>2</sub>O: ≥ 25 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| NADH (disodium salt), Alternative-names: Disodium NADH, CAS# 606-68-8, Formula: C21H27N7Na2O14P2, MWT: 709.4047, Solubility: H<sub>2</sub>O: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| RO8994, Alternative-names: , CAS# 1309684-94-3, Formula: C31H31Cl2FN4O4, MWT: 613.5067, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: No Development Reported, Pathway: Apoptosis, Target: MDM-2/p53, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SAR405838, Alternative-names: MI-77301, CAS# 1303607-60-4, Formula: C29H34Cl2FN3O3, MWT: 562.503, Solubility: 10 mM in DMSO, Clinical_Information: Phase 1, Pathway: Apoptosis, Target: MDM-2/p53, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Tedizolid (phosphate), Alternative-names: TR-701FA, CAS# 856867-55-5, Formula: C17H16FN6O6P, MWT: 450.3177, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cyclophosphamide (hydrate), Alternative-names: Cyclophosphamide monohydrate, CAS# 6055-19-2, Formula: C7H17Cl2N2O3P, MWT: 279.1012, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: DNA Alkylator/Crosslinker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| EPZ020411, Alternative-names: , CAS# 1700663-41-7, Formula: C25H38N4O3, MWT: 442.5942, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| INT-767, Alternative-names: , CAS# 1000403-03-1, Formula: C25H43NaO6S, MWT: 494.6601, Solubility: DMSO: ≥ 205.5 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease;GPCR/G Protein, Target: FXR;GPCR19, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Nampt-IN-1, Alternative-names: , CAS# 1698878-14-6, Formula: C20H25N3O5S, MWT: 419.4946, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Nampt, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Afloqualone, Alternative-names: , CAS# 56287-74-2, Formula: C16H14FN3O, MWT: 283.3003, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Imidapril (hydrochloride), Alternative-names: TA-6366, CAS# 89396-94-1, Formula: C20H28ClN3O6, MWT: 441.9058, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| PF-04418948, Alternative-names: , CAS# 1078166-57-0, Formula: C23H20FNO5, MWT: 409.407, Solubility: 10 mM in DMSO, Clinical_Information: Phase 1, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| TAS-301, Alternative-names: , CAS# 193620-69-8, Formula: C23H19NO3, MWT: 357.4019, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: No Development Reported, Pathway: TGF-beta/Smad;Epigenetics, Target: PKC;PKC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| AMI-1, Alternative-names: , CAS# 20324-87-2, Formula: C21H14N2Na2O9S2, MWT: 548.4534, Solubility: DMSO: ≥ 46 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Carvedilol (phosphate hemihydrate), Alternative-names: , CAS# 610309-89-2, Formula: C24H26N2O4 . H3PO4 .1/2H2O, MWT: 513.48, Solubility: DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Papaverine (hydrochloride), Alternative-names: , CAS# 61-25-6, Formula: C20H22ClNO4, MWT: 375.846, Solubility: DMSO: 6.4 mg/mL (Need ultrasonic and warming), Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| SBI-0206965, Alternative-names: , CAS# 1884220-36-3, Formula: C21H21BrN4O5, MWT: 489.3192, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: ULK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Enasidenib, Alternative-names: AG-221, CAS# 1446502-11-9, Formula: C19H17F6N7O, MWT: 473.375, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Isocitrate Dehydrogenase (IDH), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| 1,2,3,4,6-Penta-O-galloyl-beta-D-glucopyranose, Alternative-names: Penta-O-galloyl-β-D-glucose, CAS# 14937-32-7, Formula: C41H32O26, MWT: 940.6772, Solubility: DMSO: 10 mM; H<sub>2</sub>O: 6 mg/mL (Need ultrasonic and warming), Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Loganin, Alternative-names: Loganoside, CAS# 18524-94-2, Formula: C17H26O10, MWT: 390.3824, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Norvancomycin (hydrochloride), Alternative-names: Desmethyl-vancomycin hydrochloride, CAS# 213997-73-0, Formula: C65H74Cl3N9O24, MWT: 1471.688, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Magnolol, Alternative-names: , CAS# 528-43-8, Formula: C18H18O2, MWT: 266.3343, Solubility: DMSO: ≥ 37 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease;Cell Cycle/DNA Damage;Autophagy;NF-κB, Target: RAR/RXR;PPAR;Autophagy;PPAR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| CHF5074, Alternative-names: CSP-1103;Itanapraced, CAS# 749269-83-8, Formula: C16H11Cl2FO2, MWT: 325.1617, Solubility: DMSO: ≥ 37 mg/mL, Clinical_Information: Phase 1, Pathway: Stem Cell/Wnt;Neuronal Signaling, Target: γ-secretase;γ-secretase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cefoperazone (sodium salt), Alternative-names: CP 52640-2, CAS# 62893-20-3, Formula: C25H26N9NaO8S2, MWT: 667.6492, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| 3,6-Dichlorotrimellitic anhydride, Alternative-names: , CAS# 81742-10-1, Formula: C9H2Cl2O5, MWT: 261.0152, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| 3,6-Dichlorotrimellitic acid, Alternative-names: , CAS# 137071-78-4, Formula: C9H4Cl2O6, MWT: 279.0305, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Dansyl chloride, Alternative-names: DNSCl, CAS# 605-65-2, Formula: C12H12ClNO2S, MWT: 269.7472, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| CY2, Alternative-names: , CAS# 260430-02-2, Formula: C25H26N2O4, MWT: 418.485, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CY2-SE, Alternative-names: , CAS# 186205-33-4, Formula: C29H30IN3O6, MWT: 643.4695, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| AZD3759, Alternative-names: , CAS# 1626387-80-1, Formula: C22H23ClFN5O3, MWT: 459.9011, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: JAK/STAT Signaling;Protein Tyrosine Kinase/RTK, Target: EGFR;EGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CY7, Alternative-names: , CAS# 943298-08-6, Formula: C35H42N2O8S2, MWT: 682.8466, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CY7-SE, Alternative-names: , CAS# 477908-53-5, Formula: C39H45N3O10S2, MWT: 779.9187, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CY3-SE, Alternative-names: Cy3 NHS Ester, CAS# 146368-16-3, Formula: C35H41N3O10S2, MWT: 727.8441, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CY3, Alternative-names: , CAS# 146368-13-0, Formula: C31H38N2O8S2, MWT: 630.772, Solubility: DMSO: 16 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CY5, Alternative-names: , CAS# 146368-11-8, Formula: C33H40N2O8S2, MWT: 656.8093, Solubility: H<sub>2</sub>O: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CY3-N3, Alternative-names: , CAS# 1621101-43-6, Formula: C36H46N6O7S2, MWT: 738.9164, Solubility: 10 mM in DMSO; H<sub>2</sub>O: < 7.4 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CY5-YNE, Alternative-names: , CAS# 1345823-20-2, Formula: C36H43N3O7S2, MWT: 693.8725, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CY5-SE, Alternative-names: Cy5 NHS Ester, CAS# 146368-14-1, Formula: C37H43N3O10S2, MWT: 753.8814, Solubility: DMSO: ≥ 26 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CY3-YNE, Alternative-names: , CAS# 1010386-62-5, Formula: C34H42N3O7S2+, MWT: 668.8427, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| 6-ROX, Alternative-names: 6-Carboxy-X-rhodamine, CAS# 194785-18-7, Formula: C33H30N2O5, MWT: 534.6017, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| 5(6)-ROX, Alternative-names: 5(6)-Carboxy-X-rhodamine, CAS# 198978-94-8, Formula: C33H30N2O5, MWT: 534.6, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| 5-ROX, Alternative-names: 5-Carboxy-X-rhodamine, CAS# 216699-35-3, Formula: C33H30N2O5, MWT: 534.6017, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Calcein (tetraethyl ester), Alternative-names: Fluorexon tetraethyl ester, CAS# 1170856-93-5, Formula: C38H42N2O13, MWT: 734.7457, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Cilobradine (hydrochloride), Alternative-names: DK-AH 269, CAS# 186097-54-1, Formula: C28H39ClN2O5, MWT: 519.0726, Solubility: DMSO, Clinical_Information: Phase 1, Pathway: Membrane Transporter/Ion Channel, Target: HCN Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| ONO-4059 (analog), Alternative-names: , CAS# 1351635-67-0, Formula: C25H24N6O3, MWT: 456.4965, Solubility: DMSO: ≥ 29 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: Btk, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| WEHI-345, Alternative-names: , CAS# 1354825-58-3, Formula: C22H23N7O, MWT: 401.4643, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Apoptosis, Target: RIP kinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| UMI-77, Alternative-names: , CAS# 518303-20-3, Formula: C18H14BrNO5S2, MWT: 468.3415, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: No Development Reported, Pathway: Apoptosis, Target: Bcl-2 Family, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| OTS514, Alternative-names: , CAS# 1338540-63-8, Formula: C21H20N2O2S, MWT: 364.4607, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| IB-MECA, Alternative-names: Piclidenoson;CF-101, CAS# 152918-18-8, Formula: C18H19IN6O4, MWT: 510.2857, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adenosine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 25mg |
| Kenpaullone, Alternative-names: 9-Bromopaullone;NSC-664704, CAS# 142273-20-9, Formula: C16H11BrN2O, MWT: 327.1754, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt;PI3K/Akt/mTOR;Cell Cycle/DNA Damage, Target: GSK-3;GSK-3;CDK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| N6-Cyclohexyladenosine, Alternative-names: CHA, CAS# 36396-99-3, Formula: C16H23N5O4, MWT: 349.3849, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adenosine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Paritaprevir, Alternative-names: ABT-450;Veruprevir, CAS# 1216941-48-8, Formula: C40H43N7O7S, MWT: 765.8771, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Anti-infection, Target: HCV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| LY354740, Alternative-names: Eglumegad;Eglumetad, CAS# 176199-48-7, Formula: C8H11NO4, MWT: 185.1772, Solubility: DMSO: < 1.9 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: mGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Solithromycin, Alternative-names: CEM-101;OP-1068, CAS# 760981-83-7, Formula: C43H65FN6O10, MWT: 845.0088, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Phase 3, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2mg |
| Oritavancin (diphosphate), Alternative-names: LY333328 diphosphate, CAS# 192564-14-0, Formula: C86H103Cl3N10O34P2, MWT: 1989.091, Solubility: DMSO: 14 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| O4I2, Alternative-names: , CAS# 165682-93-9, Formula: C12H11ClN2O2S, MWT: 282.7459, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt, Target: Oct3/4, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| BRD7116, Alternative-names: , CAS# 329059-55-4, Formula: C28H36N2O4S, MWT: 496.6614, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Ornidazole (Levo-), Alternative-names: (S)-Ornidazole;Levornidazole, CAS# 166734-83-4, Formula: C7H10ClN3O3, MWT: 219.6256, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: Bacterial;Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Morinidazole, Alternative-names: , CAS# 92478-27-8, Formula: C11H18N4O4, MWT: 270.285, Solubility: DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Morinidazole (R enantiomer), Alternative-names: R-Morinidazole, CAS# 898230-59-6, Formula: C11H18N4O4, MWT: 270.28502, Solubility: DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Dextrorotation nimorazole phosphate ester, Alternative-names: , CAS# 1124347-33-6, Formula: C11H19N4O7P, MWT: 350.264922, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: Bacterial;Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| AF-353, Alternative-names: Ro-4, CAS# 865305-30-2, Formula: C14H17IN4O2, MWT: 400.21485, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: P2X Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SIBA, Alternative-names: 5'-Isobutylthioadenosine;5'-Deoxy-5'-isobutylthioadenosine, CAS# 35899-54-8, Formula: C14H21N5O3S, MWT: 339.4132, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tranilast (trans-), Alternative-names: trans-Tranilast, CAS# 70806-55-2, Formula: C18H17NO5, MWT: 327.33128, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Angiotensin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| O4I1, Alternative-names: , CAS# 175135-47-4, Formula: C16H15NO2, MWT: 253.2958, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt, Target: Oct3/4, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Quisinostat, Alternative-names: JNJ-26481585, CAS# 875320-29-9, Formula: C21H26N6O2, MWT: 394.4702, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PF-4840154, Alternative-names: , CAS# 1332708-14-1, Formula: C26H38N6O2, MWT: 466.6189, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: TRP Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| N6-(4-Hydroxybenzyl)adenosine, Alternative-names: Para-topolin riboside, CAS# 110505-75-4, Formula: C17H19N5O5, MWT: 373.3633, Solubility: DMSO：≥ 3.8 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: P2Y Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| A2AR-agonist-1, Alternative-names: , CAS# 41552-95-8, Formula: C20H22N6O4, MWT: 410.4265, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adenosine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| KC7F2, Alternative-names: , CAS# 927822-86-4, Formula: C16H16Cl4N2O4S4, MWT: 570.3812, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: HIF/HIF Prolyl-Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Ozanimod, Alternative-names: RPC-1063, CAS# 1306760-87-1, Formula: C23H24N4O3, MWT: 404.4617, Solubility: DMSO: ≥ 29 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: LPL Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 25mg |
| ISX-9, Alternative-names: Isoxazole 9, CAS# 832115-62-5, Formula: C11H10N2O2S, MWT: 234.2743, Solubility: DMSO: ≥ 37 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Wortmannin, Alternative-names: SL-2052;KY-12420, CAS# 19545-26-7, Formula: C23H24O8, MWT: 428.4319, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: PI3K/Akt/mTOR;Cell Cycle/DNA Damage;PI3K/Akt/mTOR;Cell Cycle/DNA Damage;PI3K/Akt/mTOR, Target: DNA-PK;DNA-PK;PI3K;ATM/ATR;ATM/ATR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Nitroprusside (disodium dihydrate), Alternative-names: Sodium nitroprusside dihydrate;Sodium Nitroferricyanide(III) Dihydrate, CAS# 13755-38-9, Formula: C5H4FeN6Na2O3, MWT: 297.9482, Solubility: DMSO: ≥ 46 mg/mL, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Pyrrolidinedithiocarbamate (ammonium), Alternative-names: Ammonium pyrrolidinedithiocarbamate;APDC;1-Pyrrolidinedithiocarboxylic acid ammonium salt, CAS# 5108-96-3, Formula: C5H12N2S2, MWT: 164.2922, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: Phase 3, Pathway: NF-κB, Target: NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Lipoic acid, Alternative-names: (R)-(+)-α-Lipoic acid;alpha-Lipoic acid;R-(+)-Thioctic acid, CAS# 1200-22-2, Formula: C8H14O2S2, MWT: 206.3256, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: NF-κB, Target: NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| L-NAME (hydrochloride), Alternative-names: NG-Nitroarginine methyl ester hydrochloride, CAS# 51298-62-5, Formula: C7H16ClN5O4, MWT: 269.686, Solubility: H<sub>2</sub>O: ≥ 32 mg/mL, Clinical_Information: Phase 4, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cabotegravir, Alternative-names: GSK-1265744;S/GSK1265744, CAS# 1051375-10-0, Formula: C19H17F2N3O5, MWT: 405.3522, Solubility: DMSO: 12.67 mg/mL, Clinical_Information: Phase 3, Pathway: Metabolic Enzyme/Protease;Anti-infection, Target: HIV Integrase;HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| ROR gamma-t-IN-1, Alternative-names: , CAS# 1426802-50-7, Formula: C23H18Cl2F3NO4S, MWT: 532.3596, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: ROR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Chlormethine (hydrochloride), Alternative-names: Mechlorethamine hydrochloride, CAS# 55-86-7, Formula: C5H12Cl3N, MWT: 192.5145, Solubility: DMSO: ≥ 37 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cyclo(RADfK), Alternative-names: c(RADfK), CAS# 756500-23-9, Formula: C28H43N9O7, MWT: 617.6971, Solubility: H<sub>2</sub>O: ≥ 25 mg/mL, Clinical_Information: No Development Reported, Pathway: Cytoskeleton, Target: Integrin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| Endoxifen (Z-isomer), Alternative-names: , CAS# 112093-28-4, Formula: C25H27NO2, MWT: 373.4874, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others;Membrane Transporter/Ion Channel, Target: Estrogen Receptor/ERR;Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| STF-31, Alternative-names: , CAS# 724741-75-7, Formula: C23H25N3O3S, MWT: 423.5279, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| BG45, Alternative-names: , CAS# 926259-99-6, Formula: C11H10N4O, MWT: 214.2233, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Pipobroman, Alternative-names: , CAS# 54-91-1, Formula: C10H16Br2N2O2, MWT: 356.0542, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| IDO-IN-4, Alternative-names: , CAS# 1629125-65-0, Formula: C26H35N3O3, MWT: 437.5744, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Indoleamine 2,3-Dioxygenase (IDO), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| IDO-IN-8, Alternative-names: , CAS# 1402837-77-7, Formula: C18H21FN2O2, MWT: 316.3699, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Indoleamine 2,3-Dioxygenase (IDO), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Navoximod, Alternative-names: GDC-0919;NLG919, CAS# 1402837-78-8, Formula: C18H21FN2O2, MWT: 316.3699, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Indoleamine 2,3-Dioxygenase (IDO), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| IDO-IN-6, Alternative-names: , CAS# 1402837-76-6, Formula: C18H21FN2O2, MWT: 316.3699, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Indoleamine 2,3-Dioxygenase (IDO), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| IDO-IN-5, Alternative-names: , CAS# 1402837-79-9, Formula: C18H21FN2O2, MWT: 316.3699, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Indoleamine 2,3-Dioxygenase (IDO), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| GDC-0994 (hydrochloride), Alternative-names: Ravoxertinib hydrochloride, CAS# 2070009-58-2, Formula: C21H19Cl2FN6O2, MWT: 477.319, Solubility: DMSO, Clinical_Information: Phase 1, Pathway: Stem Cell/Wnt;MAPK/ERK Pathway, Target: ERK;ERK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SBC-115076, Alternative-names: , CAS# 489415-96-5, Formula: C31H33N3O5, MWT: 527.6108, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| GlyT2-IN-1, Alternative-names: , CAS# 448947-81-7, Formula: C13H8Cl2N4S2, MWT: 355.2654, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GlyT;GlyT, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cortisone, Alternative-names: 17-Hydroxy-11-dehydrocorticosterone;Kendall's compound E, CAS# 53-06-5, Formula: C21H28O5, MWT: 360.444, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Endoxifen (Z-isomer hydrochloride), Alternative-names: , CAS# 1032008-74-4, Formula: C25H28ClNO2, MWT: 409.9483, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others;Membrane Transporter/Ion Channel, Target: Estrogen Receptor/ERR;Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| Exendin-4 (Acetate), Alternative-names: Exenatide acetate, CAS# 914454-01-6, Formula: C186H286N50O62S, MWT: 4246.624, Solubility: DMSO, Clinical_Information: Phase 4, Pathway: GPCR/G Protein, Target: Glucagon Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| Argireline, Alternative-names: Acetyl hexapeptide-3, CAS# 616204-22-9, Formula: C34H60N14O12S, MWT: 888.9918, Solubility: H<sub>2</sub>O: 8.8 mg/mL; DMSO: < 8 mg/mL, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| (S)-Gossypol (acetic acid), Alternative-names: (S)-(+)-Gossypol acetic acid, CAS# 1189561-66-7, Formula: C32H34O10, MWT: 578.61, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Apoptosis, Target: Bcl-2 Family, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| LX7101, Alternative-names: , CAS# 1192189-69-7, Formula: C23H29N7O3, MWT: 451.5215, Solubility: DMSO: ≥ 24 mg/mL, Clinical_Information: Phase 2, Pathway: TGF-beta/Smad;Stem Cell/Wnt;Cell Cycle/DNA Damage, Target: ROCK;ROCK;ROCK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2mg |
| K-Ras(G12C) inhibitor 12, Alternative-names: , CAS# 1469337-95-8, Formula: C15H17ClIN3O3, MWT: 449.6713, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Ras, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Corticosterone, Alternative-names: 17-Deoxycortisol;11β,21-Dihydroxyprogesterone;Kendall's compound B, CAS# 50-22-6, Formula: C21H30O4, MWT: 346.4605, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Membrane Transporter/Ion Channel, Target: Monoamine Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Cholesterol, Alternative-names: , CAS# 57-88-5, Formula: C27H46O, MWT: 386.65354, Solubility: DMSO: 0.79 mg/mL (Need warming), Clinical_Information: Phase 4, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| PF-AKT400, Alternative-names: AKT protein kinase inhibitor, CAS# 1004990-28-6, Formula: C20H22F2N6O, MWT: 400.4250864, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: PI3K/Akt/mTOR, Target: Akt, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| BQU57, Alternative-names: , CAS# 1637739-82-2, Formula: C16H13F3N4O, MWT: 334.2958296, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Ras, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| SC79, Alternative-names: , CAS# 305834-79-1, Formula: C17H17ClN2O5, MWT: 364.7803, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: PI3K/Akt/mTOR, Target: Akt, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| BAY 11-7082, Alternative-names: BAY 11-7821, CAS# 19542-67-7, Formula: C10H9NO2S, MWT: 207.249, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage;Autophagy;NF-κB, Target: Deubiquitinase;Autophagy;NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cobalt phthalocyanine, Alternative-names: Cobalt(II) phthalocyanine;Cobaltous phthalocyanine;Phthalocyanine cobalt complex, CAS# 3317-67-7, Formula: C32H16CoN8, MWT: 571.4562, Solubility: DMSO: < 5.8 mg/mL; H<sub>2</sub>O: < 5.6 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| FLT3-IN-2, Alternative-names: 2-Pyridinamine, 5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[4-(trifluoromethyl)phenyl]methyl]-, CAS# 923562-23-6, Formula: C21H16ClF3N4, MWT: 416.8268, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: FLT3, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Noscapine, Alternative-names: (S,R)-Noscapine, CAS# 128-62-1, Formula: C22H23NO7, MWT: 413.4205, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Autophagy;GPCR/G Protein, Target: Autophagy;Sigma Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| NCT-501, Alternative-names: , CAS# 1802088-50-1, Formula: C21H32N6O3, MWT: 416.5172, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Aldehyde Dehydrogenase (ALDH), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Azeliragon, Alternative-names: TTP488, CAS# 603148-36-3, Formula: C32H38ClN3O2, MWT: 532.116, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Aprotinin, Alternative-names: , CAS# 9087-70-1, Formula: C284H432N84O79S7, MWT: 6511.439, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Phase 4, Pathway: Anti-infection, Target: Influenza Virus, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Mutant IDH1-IN-2, Alternative-names: , CAS# 1429176-69-1, Formula: C24H31F2N5O2, MWT: 459.532, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Isocitrate Dehydrogenase (IDH), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| L189, Alternative-names: , CAS# 64232-83-3, Formula: C11H10N4OS, MWT: 246.2883, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: DNA/RNA Synthesis, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| OTS-964, Alternative-names: , CAS# 1338545-07-5, Formula: C23H25ClN2O2S, MWT: 428.9748, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway, Target: MEK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Ivosidenib, Alternative-names: AG-120;AG 120;AG120, CAS# 1448347-49-6, Formula: C28H22ClF3N6O3, MWT: 582.9608896, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Phase 3, Pathway: Metabolic Enzyme/Protease, Target: Isocitrate Dehydrogenase (IDH), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PLX8394, Alternative-names: , CAS# 1393466-87-9, Formula: C25H21F3N6O3S, MWT: 542.5328, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Phase 2, Pathway: MAPK/ERK Pathway, Target: Raf, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Adjudin, Alternative-names: AF-2364, CAS# 252025-52-8, Formula: C15H12Cl2N4O, MWT: 335.188, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: NF-κB, Target: NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| LLY-507, Alternative-names: , CAS# 1793053-37-8, Formula: C36H42N6O, MWT: 574.7583, Solubility: DMSO: 15 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 25mg |
| Sulfaclozine, Alternative-names: Sulfachloropyrazine, CAS# 102-65-8, Formula: C10H9ClN4O2S, MWT: 284.722, Solubility: DMSO: ≥ 29 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: Bacterial;Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Aldose reductase-IN-1, Alternative-names: , CAS# 1355612-71-3, Formula: C17H10F3N5O3S, MWT: 421.3532, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Aldose Reductase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PLX7904, Alternative-names: , CAS# 1393465-84-3, Formula: C24H22F2N6O3S, MWT: 512.5317, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway, Target: Raf, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Lumefantrine, Alternative-names: Benflumetol, CAS# 82186-77-4, Formula: C30H32Cl3NO, MWT: 528.9402, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy;Anti-infection, Target: Autophagy;Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Sodium Fluoride, Alternative-names: , CAS# 7681-49-4, Formula: FNa, MWT: 41.98817, Solubility: H<sub>2</sub>O: ≥ 50 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Tartaric acid (disodium dihydrate), Alternative-names: Sodium tartrate dibasic dihydrate;Sodium tartrate dihydrate, CAS# 6106-24-7, Formula: C4H10Na2O8+2, MWT: 232.0958, Solubility: H<sub>2</sub>O: ≥ 66.66 mg/mL, Clinical_Information: Phase 1, Pathway: Metabolic Enzyme/Protease, Target: Phosphatase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Sodium molybdate, Alternative-names: Molybdate disodium, CAS# 7631-95-0, Formula: MoNa2O4, MWT: 205.9371, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Sodium orthovanadate, Alternative-names: Sodium vanadate, CAS# 13721-39-6, Formula: Na3O4V, MWT: 183.90840784, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Phosphatase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Imidazole, Alternative-names: 1,3-Diaza-2,4-cyclopentadiene;Glyoxaline, CAS# 288-32-4, Formula: C3H4N2, MWT: 68.07726, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Quinagolide (hydrochloride), Alternative-names: CV205-502 hydrochloride, CAS# 94424-50-7, Formula: C20H34ClN3O3S, MWT: 432.0203, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Perphenazine, Alternative-names: , CAS# 58-39-9, Formula: C21H26ClN3OS, MWT: 403.9686, Solubility: DMSO: ≥ 4.1 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;Immunology/Inflammation;GPCR/G Protein;GPCR/G Protein;Neuronal Signaling;GPCR/G Protein, Target: Dopamine Receptor;Dopamine Receptor;Histamine Receptor;Histamine Receptor;Adrenergic Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| hPGDS-IN-1, Alternative-names: , CAS# 1234708-04-3, Formula: C22H20N6O3, MWT: 416.4326, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: PGE synthase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Citarinostat, Alternative-names: ACY241;ACY-241;ACY 241, CAS# 1316215-12-9, Formula: C24H26ClN5O3, MWT: 467.9479, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Phase 1, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| ITE, Alternative-names: , CAS# 448906-42-1, Formula: C14H10N2O3S, MWT: 286.3058, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Bafetinib, Alternative-names: INNO-406;NS-187, CAS# 859212-16-1, Formula: C30H31F3N8O, MWT: 576.6154, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: Phase 2, Pathway: Protein Tyrosine Kinase/RTK;Autophagy, Target: Bcr-Abl;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| A-1210477, Alternative-names: , CAS# 1668553-26-1, Formula: C46H55N7O7S, MWT: 850.0366, Solubility: DMSO: < 4.8 mg/mL, Clinical_Information: No Development Reported, Pathway: Apoptosis, Target: Bcl-2 Family, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| CB1-IN-1, Alternative-names: , CAS# 1429239-98-4, Formula: C33H31Cl2F3N6O3S2, MWT: 751.6688, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Cannabinoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| KPT-9274, Alternative-names: , CAS# 1643913-93-2, Formula: C35H29F3N4O3, MWT: 610.625, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Phase 1, Pathway: Cytoskeleton;Cell Cycle/DNA Damage, Target: PAK;PAK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| NSC305787, Alternative-names: , CAS# 785718-37-8, Formula: C25H30Cl2N2O, MWT: 445.4245, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: TGF-beta/Smad;Epigenetics, Target: PKC;PKC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| ACY-738, Alternative-names: , CAS# 1375465-91-0, Formula: C14H14N4O2, MWT: 270.2866, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| D-Pantothenic acid (sodium), Alternative-names: Sodium pantothenate;vitamin B5 sodium, CAS# 867-81-2, Formula: C9H16NNaO5, MWT: 241.2168, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Isoconazole (nitrate), Alternative-names: , CAS# 24168-96-5, Formula: C18H15Cl4N3O4, MWT: 479.1414, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: Fungal;Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Benidipine (hydrochloride), Alternative-names: KW-3049, CAS# 91599-74-5, Formula: C28H32ClN3O6, MWT: 542.0232, Solubility: DMSO: 15 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Uridin, Alternative-names: β-Uridine, CAS# 58-96-8, Formula: C9H12N2O6, MWT: 244.2014, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Levobetaxolol (hydrochloride), Alternative-names: (S)-Betaxolol hydrochloride;AL-1577A, CAS# 116209-55-3, Formula: C18H30ClNO3, MWT: 343.8887, Solubility: DMSO：≥ 39 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Chlorzoxazone, Alternative-names: , CAS# 95-25-0, Formula: C7H4ClNO2, MWT: 169.5652, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Cytochrome P450, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Domiphen (bromide), Alternative-names: , CAS# 538-71-6, Formula: C22H40BrNO, MWT: 414.4631, Solubility: DMSO: ≥ 52 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Isosorbide, Alternative-names: D-Isosorbide;Dianhydro-D-glucitol, CAS# 652-67-5, Formula: C6H10O4, MWT: 146.1412, Solubility: H<sub>2</sub>O: ≥ 42 mg/mL, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Azaperone, Alternative-names: , CAS# 1649-18-9, Formula: C19H22FN3O, MWT: 327.3959, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Deoxycorticosterone (acetate), Alternative-names: 11-Deoxycorticosterone acetate;DOC acetate;Cortexone acetate, CAS# 56-47-3, Formula: C23H32O4, MWT: 372.4978, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Mineralocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tolmetin (sodium dihydrate), Alternative-names: , CAS# 64490-92-2, Formula: C15H18NNaO5, MWT: 315.2969, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL; DMSO: < 8.8 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tranylcypromine (hemisulfate), Alternative-names: dl-Tranylcypromine hemisulfate;trans-2-Phenylcyclopropylamine hemisulfate salt, CAS# 13492-01-8, Formula: C9H12NO2S0.5, MWT: 182.23, Solubility: H<sub>2</sub>O: 46.66 mg/mL (Need ultrasonic); DMSO: < 5.2 mg/mL, Clinical_Information: Launched, Pathway: Epigenetics;Neuronal Signaling, Target: Histone Demethylase;Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| ETC-159, Alternative-names: ETC-1922159, CAS# 1638250-96-0, Formula: C19H17N7O3, MWT: 391.3834, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: Phase 1, Pathway: Stem Cell/Wnt, Target: Wnt, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PX-478, Alternative-names: , CAS# 685898-44-6, Formula: C13H20Cl4N2O3, MWT: 394.1215, Solubility: H<sub>2</sub>O: ≥ 35 mg/mL, Clinical_Information: Phase 1, Pathway: Autophagy;Metabolic Enzyme/Protease, Target: Autophagy;HIF/HIF Prolyl-Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Spirodiclofen, Alternative-names: BAJ-2740, CAS# 148477-71-8, Formula: C21H24Cl2O4, MWT: 411.3188, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dinotefuran, Alternative-names: MTI-446, CAS# 165252-70-0, Formula: C7H14N4O3, MWT: 202.2111, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel;Anti-infection, Target: nAChR;nAChR;Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Emamectin (Benzoate), Alternative-names: , CAS# 155569-91-8, Formula: C104H154N2O28, MWT: 1880.332, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Carbosulfan, Alternative-names: , CAS# 55285-14-8, Formula: C20H32N2O3S, MWT: 380.5447, Solubility: DMSO: ≥ 68 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Cytochrome P450, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ca2+ channel agonist 1, Alternative-names: , CAS# 1402821-24-2, Formula: C19H26N6O, MWT: 354.4493, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel;Cell Cycle/DNA Damage, Target: Calcium Channel;CDK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Fmoc-Val-Cit-PAB, Alternative-names: , CAS# 159858-22-7, Formula: C33H39N5O6, MWT: 601.6927, Solubility: DMSO: ≥ 123.75 mg/mL, Clinical_Information: No Development Reported, Pathway: Antibody-drug Conjugate/ADC Related, Target: ADC Linker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Val-cit-PAB-OH, Alternative-names: , CAS# 159857-79-1, Formula: C18H29N5O4, MWT: 379.4539, Solubility: DMSO: ≥ 59 mg/mL, Clinical_Information: No Development Reported, Pathway: Antibody-drug Conjugate/ADC Related, Target: ADC Linker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fmoc-Val-Cit-PAB-PNP, Alternative-names: , CAS# 863971-53-3, Formula: C40H42N6O10, MWT: 766.79568, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Antibody-drug Conjugate/ADC Related, Target: ADC Linker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Yohimbine, Alternative-names: , CAS# 146-48-5, Formula: C21H26N2O3, MWT: 354.4427, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| ODM-201, Alternative-names: BAY-1841788;Darolutamide, CAS# 1297538-32-9, Formula: C19H19ClN6O2, MWT: 398.8462, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: Phase 3, Pathway: Others, Target: Androgen Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| CEP-28122, Alternative-names: , CAS# 1022958-60-6, Formula: C28H35ClN6O3, MWT: 539.0689, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: ALK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| HA130, Alternative-names: HA-130, CAS# 1229652-21-4, Formula: C24H19BFNO5S, MWT: 463.2858, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Phase 3, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| L-SelenoMethionine, Alternative-names: , CAS# 3211-76-5, Formula: C5H11NO2Se, MWT: 196.1063, Solubility: H<sub>2</sub>O: 11 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Terbuthylazine, Alternative-names: , CAS# 5915-41-3, Formula: C9H16ClN5, MWT: 229.7098, Solubility: DMSO: 23 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Terbutryn, Alternative-names: , CAS# 886-50-0, Formula: C10H19N5S, MWT: 241.3564, Solubility: DMSO: ≥ 25 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Akt1 and Akt2-IN-1, Alternative-names: , CAS# 893422-47-4, Formula: C33H29N7O, MWT: 539.6296, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: No Development Reported, Pathway: PI3K/Akt/mTOR, Target: Akt, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cortodoxone, Alternative-names: 11-Deoxycortisol;cortexolone;Reichstein's substance S, CAS# 152-58-9, Formula: C21H30O4, MWT: 346.4605, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Epiandrosterone, Alternative-names: 3β-Androsterone;trans-Androsterone;iso-Androsterone, CAS# 481-29-8, Formula: C19H30O2, MWT: 290.4403, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Androgen Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Uramustine, Alternative-names: Uracil mustard, CAS# 66-75-1, Formula: C8H11Cl2N3O2, MWT: 252.0978, Solubility: DMSO: ≥ 29 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: DNA Alkylator/Crosslinker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Moxalactam (sodium salt), Alternative-names: Latamoxef sodium;LY-127935;Antibiotic 6059S, CAS# 64953-12-4, Formula: C20H18N6Na2O9S, MWT: 564.4363, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| AZD6738, Alternative-names: , CAS# 1352226-88-0, Formula: C20H24N6O2S, MWT: 412.5085, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Phase 2, Pathway: Cell Cycle/DNA Damage;PI3K/Akt/mTOR, Target: ATM/ATR;ATM/ATR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Deoxyarbutin, Alternative-names: , CAS# 53936-56-4, Formula: C11H14O3, MWT: 194.2271, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Tyrosinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Quetiapine sulfoxide (dihydrochloride), Alternative-names: Quetiapine sulfoxide dihydrochloride;Quetiapine S-oxide dihydrochloride, CAS# 329218-11-3, Formula: C21H27Cl2N3O3S, MWT: 472.4284, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Neuronal Signaling;Neuronal Signaling;GPCR/G Protein, Target: Dopamine Receptor;Dopamine Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| ORM-15341, Alternative-names: , CAS# 1297537-33-7, Formula: C19H17ClN6O2, MWT: 396.8303, Solubility: DMSO: ≥ 37 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Androgen Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| AZ-5104, Alternative-names: , CAS# 1421373-98-9, Formula: C27H31N7O2, MWT: 485.5807, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: No Development Reported, Pathway: JAK/STAT Signaling;Protein Tyrosine Kinase/RTK, Target: EGFR;EGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| (S)-10-Hydroxycamptothecin, Alternative-names: 10-HCPT;10-Hydroxycamptothecin, CAS# 19685-09-7, Formula: C20H16N2O5, MWT: 364.3514, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Litronesib, Alternative-names: LY-2523355;KF-89617, CAS# 910634-41-2, Formula: C23H37N5O4S2, MWT: 511.701, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Cytoskeleton;Cell Cycle/DNA Damage, Target: Kinesin;Kinesin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Leupeptin (hemisulfate), Alternative-names: , CAS# 103476-89-7, Formula: C20H38N6O4 . 1/2H2SO4, MWT: 475.59, Solubility: H<sub>2</sub>O: ≥ 19 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Cathepsin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cefpirome (sulfate), Alternative-names: , CAS# 98753-19-6, Formula: C22H24N6O9S3, MWT: 612.6558, Solubility: H<sub>2</sub>O: 5 mg/mL (Need ultrasonic and warming), Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cefetamet pivoxil (hydrochloride), Alternative-names: Ro 15-8075, CAS# 111696-23-2, Formula: C20H26ClN5O7S2, MWT: 548.0327, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Napropamide, Alternative-names: Napropamid, CAS# 15299-99-7, Formula: C17H21NO2, MWT: 271.3541, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Fenoxaprop-P-ethyl, Alternative-names: , CAS# 71283-80-2, Formula: C18H16ClNO5, MWT: 361.7763, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Trifluralin, Alternative-names: , CAS# 1582-09-8, Formula: C13H16F3N3O4, MWT: 335.2791, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Tolclofos-methyl, Alternative-names: , CAS# 57018-04-9, Formula: C9H11Cl2O3PS, MWT: 301.1266, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Clofentezine, Alternative-names: , CAS# 74115-24-5, Formula: C14H8Cl2N4, MWT: 303.1461, Solubility: DMSO: < 8.2 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Kuromanin (chloride), Alternative-names: Chrysontemin;Cyanidin 3-O-glucoside chloride, CAS# 7084-24-4, Formula: C21H21ClO11, MWT: 484.8378, Solubility: DMSO: 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Solcitinib, Alternative-names: GSK-2586184;GLPG-0778, CAS# 1206163-45-2, Formula: C22H23N5O2, MWT: 389.4503, Solubility: DMSO: 20 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Stem Cell/Wnt;JAK/STAT Signaling, Target: JAK;JAK;JAK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PF-4989216, Alternative-names: , CAS# 1276553-09-3, Formula: C18H13FN6OS, MWT: 380.3988, Solubility: DMSO: ≥ 29 mg/mL, Clinical_Information: No Development Reported, Pathway: PI3K/Akt/mTOR, Target: PI3K, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Hexaminolevulinate (hydrochloride), Alternative-names: Hexyl 5-aminolevulinate hydrochloride;P-1206;5-Aminolevulinic acid hexyl ester hydrochloride, CAS# 140898-91-5, Formula: C11H22ClNO3, MWT: 251.7503, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 3-Methyladenine, Alternative-names: 3-MA, CAS# 5142-23-4, Formula: C6H7N5, MWT: 149.1533, Solubility: DMSO: ≥ 1.5 mg/mL; DMSO: 6.8 mg/mL (Need ultrasonic); H<sub>2</sub>O: 8.82 mg/mL (Need ultrasonic), Clinical_Information: No Development Reported, Pathway: PI3K/Akt/mTOR;Autophagy, Target: PI3K;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Troxipide, Alternative-names: , CAS# 30751-05-4, Formula: C15H22N2O4, MWT: 294.3462, Solubility: DMSO: 10.75 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Imazapic, Alternative-names: , CAS# 104098-48-8, Formula: C14H17N3O3, MWT: 275.3031, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Metaldehyde, Alternative-names: , CAS# 108-62-3, Formula: C8H16O4, MWT: 176.2102, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Oxadiazon, Alternative-names: , CAS# 19666-30-9, Formula: C15H18Cl2N2O3, MWT: 345.221, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Levodropropizine, Alternative-names: (S)-(-)-Dropropizine, CAS# 99291-25-5, Formula: C13H20N2O2, MWT: 236.3101, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Diniconazole, Alternative-names: Rac-diniconazole, CAS# 83657-24-3, Formula: C15H17Cl2N3O, MWT: 326.221, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Thifluzamide, Alternative-names: , CAS# 130000-40-7, Formula: C13H6Br2F6N2O2S, MWT: 528.0624, Solubility: DMSO: ≥ 29 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cloquintocet-mexyl, Alternative-names: , CAS# 99607-70-2, Formula: C18H22ClNO3, MWT: 335.8252, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Phosalone, Alternative-names: , CAS# 2310-17-0, Formula: C12H15ClNO4PS2, MWT: 367.8086, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Propanil, Alternative-names: , CAS# 709-98-8, Formula: C9H9Cl2NO, MWT: 218.0799, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Pyriproxyfen, Alternative-names: , CAS# 95737-68-1, Formula: C20H19NO3, MWT: 321.3698, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Chlorthal-dimethyl, Alternative-names: Dimethyl tetrachloroterephthalate, CAS# 1861-32-1, Formula: C10H6Cl4O4, MWT: 331.9642, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| AB-MECA, Alternative-names: , CAS# 152918-26-8, Formula: C18H21N7O4, MWT: 399.4038, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adenosine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Nav1.7-IN-2, Alternative-names: , CAS# 1332295-35-8, Formula: C22H22FN5O2, MWT: 407.4408, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Varlitinib, Alternative-names: ARRY-334543, CAS# 845272-21-1, Formula: C22H19ClN6O2S, MWT: 466.9433, Solubility: DMSO: 16.67 mg/mL, Clinical_Information: Phase 3, Pathway: JAK/STAT Signaling;Protein Tyrosine Kinase/RTK, Target: EGFR;EGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Dantrolene (sodium hemiheptahydrate), Alternative-names: Dantrolene sodium hydrate, CAS# 24868-20-0, Formula: C14H17N4NaO8.5, MWT: 400.3, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Autophagy, Target: Calcium Channel;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| PTACH, Alternative-names: NCH-51, CAS# 848354-66-5, Formula: C20H26N2O2S2, MWT: 390.5627, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Talampanel, Alternative-names: GYKI-53773;LY-300164, CAS# 161832-65-1, Formula: C19H19N3O3, MWT: 337.3725, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| APTO-253, Alternative-names: LOR-253;LT-253, CAS# 916151-99-0, Formula: C22H14FN5, MWT: 367.3784, Solubility: DMSO: ≥ 26 mg/mL, Clinical_Information: Phase 1, Pathway: Cytoskeleton;Cell Cycle/DNA Damage, Target: PAK;PAK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| UF010, Alternative-names: , CAS# 537672-41-6, Formula: C11H15BrN2O, MWT: 271.1536, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| WDR5-0103, Alternative-names: WD-Repeat Protein 5-0103, CAS# 890190-22-4, Formula: C21H25N3O4, MWT: 383.4409, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pimelic Diphenylamide 106, Alternative-names: RGFA-8;TC-H 106;Histone Deacetylase Inhibitor VII, CAS# 937039-45-7, Formula: C20H25N3O2, MWT: 339.4314, Solubility: DMSO: ≥ 25 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| BML-210, Alternative-names: , CAS# 537034-17-6, Formula: C20H25N3O2, MWT: 339.4314, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| MN-64, Alternative-names: , CAS# 92831-11-3, Formula: C18H16O2, MWT: 264.3185, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: PARP;PARP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| AZD3264, Alternative-names: , CAS# 1609281-86-8, Formula: C21H23N5O4S, MWT: 441.5034, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: No Development Reported, Pathway: NF-κB, Target: IKK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2mg |
| Dantrolene (sodium), Alternative-names: F 440, CAS# 14663-23-1, Formula: C14H9N4NaO5, MWT: 336.23482928, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| R112, Alternative-names: , CAS# 575474-82-7, Formula: C16H13FN4O2, MWT: 312.2984, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: Syk, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Tiamulin (fumarate), Alternative-names: Thiamutilin fumarate, CAS# 55297-96-6, Formula: C32H51NO8S, MWT: 609.8143, Solubility: DMSO: ≥ 50 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| Palmatine (chloride), Alternative-names: , CAS# 10605-02-4, Formula: C21H22ClNO4, MWT: 387.8567, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
